{
  "name" : "zero.sci-hub.se_5155_37a9aa26140a1f190d6316c6b06fabd1_katouzian2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins",
    "authors" : [ "Iman Katouzian", "Seid Mahdi Jafari" ],
    "emails" : [ "smjafari@gau.ac.ir" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nNano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins\nIman Katouzian, Seid Mahdi Jafari\nPII: S0924-2244(16)30001-2 DOI: 10.1016/j.tifs.2016.05.002 Reference: TIFS 1804\nTo appear in: Trends in Food Science & Technology\nReceived Date: 1 January 2016 Revised Date: 3 May 2016 Accepted Date: 4 May 2016\nPlease cite this article as: Katouzian, I., Jafari, S.M., Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins, Trends in Food Science & Technology (2016), doi: 10.1016/j.tifs.2016.05.002.\nThis is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nNano-encapsulation as a promising approach for targeted delivery and controlled\nrelease of vitamins\nIman Katouzian, Seid Mahdi Jafari\nGraphical Abstract\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n1\nNano-encapsulation as a promising approach for targeted delivery and controlled release of 1\nvitamins 2\nRunning Title: Nano-encapsulation of vitamins 3 Iman Katouzian1,3, Seid Mahdi Jafari1,2,3* 4 1Department of Food Materials and Process Design Engineering, Faculty of Food Technology, University of 5 Agricultural Science and Natural Resources, Gorgan, Iran. 6 2Cereals Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran. 7 3Nano-encapsulation in the Food, Nutraceutical, and Pharmaceutical Industries Group (NFNPIG), Universal 8 Scientific Education and Research Network (USERN), Tehran, Iran 9\n*Corrseponding author at Pishro Food Technology Research Group, Gorgan, Iran: 10 Tel./fax: +98 17 324 26 432. E-mail address: smjafari@gau.ac.ir (S.M. Jafari). 11 Structural abstract 12 Background 13 Vitamins are bioactive molecules necessary for human health, which are sensible to degradation. During 14 consumption, the bioavailability of these compounds might be limited due to structure break-down and low 15 absorption. Today, nanoencapsulation can be a promising approach for targeted delivery of vitamins and 16 protecting these bioactive components against destructive environment during processing and delivery. 17 Regarding the benefits of utilizing nanotechnology in the food sector, safety aspects of these tiny carriers 18 should also be clarified as this technology develops. Due to the possible negative effects of nanomaterials, 19 several agencies have legislated regulatory policies to prevent potential harms to the consumers, which are 20 underlined in this article. 21 Scope and approach 22 Nanoencapsulation-based technologies are a unique and novel field of investigation in the food and 23 pharmaceutical industry with benefits, such as higher bioavailability, high shelf-stability and controlled release 24 of active compounds. This review highlights recent works on these techniques and advances made in 25 nanoencapsulation of lipophilic and hydrophilic vitamins, safety issues and health risks regarding the 26 consumption of these products, which opens new horizons in food technology and nutrition with possibilities 27 of commercialization in the near future. 28 Key findings and conclusions 29 Recently, considerable progresses are being carried out in the field of food nanoencapsulation involving novel 30 nanovehicles to encapsulate vitamins. Nanofibers and nanohydrogels are some examples of efficient and 31 modern nanocarriers. Overall, the vitamins encapsulated within nanovehicles are considered safe since they 32 are mostly produced from food components, meanwhile more studies should be performed regarding the 33 safety issues of nanodelivery of vitamins. In near future, it is assumed that nanoencapsulated vitamins will be 34 broadly applied the in the food and beverage products. 35 Keywords: Nanoencapsulation; vitamins; food industry; safety; bioavailability. 36\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n2\n1. Introduction 37 Vitamins and antioxidants are rudimentary elements for human health as they assist the body to grow and 38 develop. Furthermore, they are able to prevent diseases and to promote general health. Unfortunately, most 39 of these bioactive agents are either produced in trifle amounts or not made in the body. Thus, vitamins need 40 to be supplied from food products and through dietary supplements if needed (Wildman, Wildman, & 41 Wallace, 2006). Some of the beneficial functions of vitamins are as follows: enhancing the immune system 42 and vision, supporting skin health and cell growth and helping to prevent cancer (vitamin A); empowering 43 the immune system, alleviate anxiety and depression, reduce stroke risk and relieve PMS (premenstrual 44 syndrome) (vitamin B-complex); raising immunity, treating common cold symptoms, maintaining healthy 45 skin, healing wounds, reducing cholesterol levels and regulating the blood sugar level, reducing neurological 46 disorders (vitamin C)(Hickey, 2009), preventing cancer and cardiovascular diseases as well as promoting 47 vigorous bones and teeth (vitamin D), restraining brain and nervous system diseases; such as, Alzheimer and 48 other dementias, boosting physical endurance and avoiding skin disorders (vitamin E), helping blood clot, 49 nerve signaling, improving bone health and regulating cellular functions (Zempleni, Suttie, Gregory III, & 50 Stover, 2013). 51 Vitamins are sensitive molecules; therefore they should be preserved from harmful agents like heat and 52 oxidants. Encapsulation is a promising and novel method for preserving the innate characteristics of vitamins 53 over time (Sanguansri & Augustin, 2006). This process includes coating or trapping a biomaterial or a 54 combination into another element. The entrapped substance is normally a liquid, while a gas or solid state 55 substance can also be carried. The coating substance is known as capsule, wall material, membrane, or 56 carrier. 57 Our body has nanoscale structures like DNA, amino acids, etc. (Weiss, Takhistov, & McClements, 2006). 58 Considering these natural nanoparticles, scientists have engineered nanomaterials for the usage in human’s 59 food and recently, there has been a tremendous progress in food nanoencapsulation. 60 In this study, after a brief review on pros and cons of food nanotechnology and microencapsulation of 61 vitamins, we will highlight recent fundamental and novel techniques used to nanoencapsulate different 62 vitamins in the food industry. Besides, issues on the characterization, controlled release and safety-63 consumption of these vital elements are described. Future trends will also be explained in the last section. 64 2. Pros and cons of applying nanotechnology in the food industry 65 Today, the entry of nanotechnology within the food sector has brought new hopes and is expected to be the 66 key to food industry’s concerns as it may bring various benefits, nevertheless like the other emerging 67 technologies it could also have risks for consumers. According to Aguilera (cited in Yaktine & Pray, 2009), 68 exerting nanotechnology in food industry may bring about various advantages and opportunities; such as, 69 developing promising nano-processes, fabricating eco-friendly processes and intelligent nano-packaging, 70 manufacturing products with desirable texture and tastes, producing low-calorie food and beverage products 71\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n3\nwith the aim of changing the lifestyles into healthy ones. He also suggested that there are still more 72 opportunities which will be accomplished by carefully studying how food components are formed, 73 disintegrated, ingested and absorbed and without this perception it wouldn’t be possible to overcome the 74 potential risks and uncertainties within this technology. 75 Regarding the risks and disadvantages of applying nanotechnology in food industry, most of the 76 nanoparticles enter the gut through oral administration and absorption via intestine cells (enterocytes) is 77 designed in a way that they do not allow large or foreign particles to pass through them, nevertheless the 78 nano-sized ingredients are able to cross these barriers, therefore there is a potential risk in bringing up gastric 79 diseases which should investigated through in vivo and clinical studies. 80 3. Microencapsulation vs. nanoencapsulation of vitamins 81 Micro/nanoencapsulation is defined as the creation of a barrier to inhibit unfavorable chemical interactions 82 and for the controlled release of bioactive ingredients especially vitamins. Importance of using the 83 microencapsulation processes for vitamins and their key features could be summarized as below: 84\n• Protection of vitamins from external environment • Controlled release of vitamins • Improved flow properties • Reduce overages • Measuring the precise level of vitamin delivery • Forming Light-scattering vitamin solutions • Being cost effective especially for spray drying method • Undesirable flavor of some vitamins are masked • Enriching the food products with a complex of vitamins\nWhile for nano-encapsulation of vitamins, the following advantages can be mentioned: 85\nFaster dissociation Higher surface area compared to mass proportion High intracellular uptake Pass along the smallest body fenestrations Enable precision targeting Reduce the reactions between vitmains and other molecules plus surrounding medium Formulating optically transparent vitamin solutions Reduction in the quantity of utilized core-shell material Rendering long-shelf life coated vitamins Reinforced physical stability against coalescence and gravitational separations\n86\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n4\nThe capsule size in microencapsulation ranges between 5-300µm in diameter (F. Gibbs, 1999). When the 87 particle size reduces to the nanoscale during nanoencapsulation, surface-to-volume ratio increases. 88 Therefore, the reactions are speeded by many folds; moreover, the mechanical, optical and electrical 89 properties of the materials will also change (Neethirajan & Jayas, 2011). Physicochemical characteristics of 90 vitamins strongly depend on the applied nanoencapsulation approach and delivery system. Thus, an 91 appropriate nanoencapsulation technique must be chosen considering the required size, physicochemical 92 properties, nature of the encapsulated vitamin and the wall material. Nanoencapsulation process is more 93 complex than microencapsulation because of the difficulty in acquiring an intricate morphology for the 94 capsule entrapping the vitamin (Chau, Wu, & Yen, 2007). 95 According to Gutiérrez, et al., (2013) casein nanoparticles were found to be more stable, cost efficient and 96 environmentally friendly when compared with microemulsions. Moreover, Danino, Livney, Ramon, Portnoy, 97 & Cogan, (2014) and Semo, Kesselman, Danino, & Livney, (2007) suggested that nanoencapsulation via ẞ-98 cyclodextrins produced satisfactory sensory properties and created optically transparent solutions, however, 99 microemulsions tend to scatter light. In a recent investigation, it was suggested that nanoliposomes have the 100 benefits to minimize the reactions between bioactives and other molecules, increasing the shelf-life of food 101 products and reducing the amount of used core-shell material compared to conventional liposomes, which are 102 biocompatible and their surface is easily modified (Fathima, Fathima, Abhishek, & Khanum, 2016). 103 Fig. 1 presents the forms of microcapsuls. The shell is responsible for protecting vitamins from water, 104 oxygen or sunlight. On the other hand, nanostructured delivery forms applied in nanoencapsulation of 105 vitamins are summarized in Fig. 2. 106 Fig. 1 107 Fig. 2 108 There are some commercially approved biopolymers for the encapsulation of vitamins. Starches and 109 cyclodextrins are carbohydrate-based biopolymers that protect these sensitive compounds from the outside 110 environment. Gum Arabic is also used in microencapsulating according to its solubility, viscosity and 111 emulsification features. However, economically it is not profitable. Alginates can also be used as a wall 112 material at environment temperatures. Ethylcellulose has been approved to be a good substance for 113 encapsulating water-soluble vitamins, because as the wall materials width rises, the water permeability of the 114 dispersed vitamins is reduced. Protein based shells may also be utilized in encapsulating different vitamins. 115 Nevertheless, their high cost is limiting factor for using them in an industrial scale. 116 4. Conventional microencapsulation techniques of vitamins 117 Before explaining the recent nanoencapsulation techniques applied in protection of vitamins, it is necessary 118 to be familiar with common microencapsulation methods used for different vitamins. Table 1 summarizes the 119 works performed on the microencapsulation of vitamins. In this section, some of the most important 120 techniques plus the literatures are presented. 121\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n5\nTable 1 122 4. 1 Spray-drying 123 It is one of the oldest encapsulation methods capable of producing encapsulated powders with different 124 particle sizes mostly utilized for encapsulating lipo-soluble vitamins in an industrial scale (Jafari, He, & 125 Bhandari, 2007a). In this procedure, all matrix substances; like, Arabic gum and maltodextrin are drenched 126 and the oil-based material is added during mixing. Later, homogenization is used to achieve an emulsion and 127 finally the yield powder is achieved through spray-drying process. The resulting powder contains 1-50% 128 (w/w) oil (Boyle & Chang, 1999). These microencapsulated vitamins are commonly used in tablets in which 129 oxidation stability and tablet properties are affected by the type of the matrix material. (Shi & Tan, 2002) 130 trapped vitamin D2 in a chitosan/ethylcellulose coating, and then examined morphology and release traits of 131 the capsuls. In vitro results showed that microcapsuls are able to remain unchanged in the intestine juice. 132 High-DE maltodextrins are hygroscopic, thus the produced powder is not desirable. A maltodextrin with a 133 25DE combined with lactose, galactose or glucose has been shown to extend the shelf life of encapsulated 134 trans-ẞ-carotene compared with commercial 25 DE maltodextrin alone (Desobry, Netto, & Labuza, 1999). 135 Spray drying has also been applied for encapsulation of water-soluble vitamins too. For example, Ascorbic 136 acid (vitamin C) is an antioxidant or vitamin supplement vastly used in the food and beverage industry, 137 which is so unstable and can be degraded by many mechanisms (Kirby, Whittle, Rigby, Coxon, & Law, 138 1991). (Desai & Park, 2005) analyzed the encapsulation of vitamin C regarding trypolyphosphate cross-139 linked chitosan microspheres as the wall material. As a result, cross-linking factor influenced the particle size 140 between 6.1-9µm. 141 4.2 Spray chilling and spray cooling 142 Both techniques involve diffusing the vitamins in a molten fat or wax. Next, this dispersion is atomized 143 through heated nozzles into a case at room temperature (spray-cooling) or low temperatures (spray-chilling). 144 At the room temperature, the melting point of the encapsulated material is between 45-122°C. At low 145 temperatures (refrigerate temperature), substances tend to melt at 32-42°C (Risch & Reineccius, 1995). 146 These microcapsuls won’t dissolve in water and as the temperature rises, the fat or wax membrane will be 147 molten. Thus, the fat-crystallization in the spray- chilling or cooling process needs to be monitored carefully. 148 This is a suitable technique for encapsulating lipid-soluble vitamins. (Wegmüller, Zimmermann, Bühr, 149 Windhab, & Hurrell, 2006) microencapsulated iron, vitamin A and iodine in hydrogenated palm fat by spray 150 cooling. After 6 months, an excellent stability of retinyl palmitate was observed and losses occurred during 151 this period was nearly 12%. 152 4.3 Emulsion technique 153 This process includes dispersing vitamins into an immiscible liquid phase, which possesses the shell 154 material. Second, adjustments are made in order to form shells around the scattered vitamins in the solution. 155 O/W is the most prevalent two phase system applied in encapsulation. (Wang, MacGillivray, & Macartney, 156\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n6\n2009) encapsulated cob (III) alamins; like, CNCbl and AdoCbl with 5,6dimethylbenzimidazole and 157 cucurbituril. The cucurbituril combined with vitamin B12 imitate the applications of chemical, photochemical 158 and electrochemical of these and other cob (III) alamins. (Leonard, Good, Gugger, & Traber, 2004) 159 encapsulated vitamin E in a breakfast cereal and compared its bioavailability to vitamin E encapsulated in 160 supplements. The capsule was made from d9-α-tocopheryl acetate (400-IU capsule). Results showed that 161 encapsulated vitamin E in supplements are poorly absorbed; however the bioavailability is increased by 162 using it in fortified-foods. (Van Hasselt, et al., 2009) used polymeric micelles to encapsulate vitamin K. They 163 compared the capsule´s absorption in bile duct legated and sham rats. As a result, the gastrointestinal 164 absorption of the microcapsuls was affected through free bile, furthermore the uptake of micelles via 165 pinocytosis was considered inconsiderable. 166 4.4 Fluidized bed coating 167 It is also known as air suspension coating. Solid particles are suspended in an upward moving flow of air 168 which can be either cool or hot. Afterwards, the solid particles are sprayed through the top of the atomized 169 particles of coating wall material, which can be molten or dissolved in an evaporable solvent (Risch & 170 Reineccius, 1995). The coating’s material can be cellulose derivatives, dextrins, emulsifiers, lipids, protein 171 derivatives and starch derivatives. This method is prevalent in nutritional supplements that contain 172 encapsulated versions of vitamin C, vitamin B complex and a variety of vitamin/mineral premixes. 173 Moreover, it can be consumed in a variety of food products including: seasonings, fillings, desserts and 174 puddings (Risch & Reineccius, 1995). (Xie, et al., 2010) reported encapsulation of vitamin C using this 175 method with the use of gelatin as the wall material. They fed larval shrimps (Penaeus japonicas) with this 176 micro-diet; as a result the wet weight of shrimps rose 300% in 10 to 30 days after hatching. The retention 177 efficiency of vitamin C estimated 88.2% in the coating procedure. 178 4.5 Liposome entrapment 179 Liposomes can be defined as single or multi-layered vesicles, which include the complete entrapment of an 180 aqueous phase in a phospholipid-based membrane. Aqueous or lipid-soluble vitamins, but not both are 181 encapsulated in these membranes. (Kirby, et al., 1991) encapsulated vitamin C with high efficiency using this 182 technique. The most stable liposomes are made of lecithin, cholesterol and negatively charged phospholipids. 183 A prevalent method for producing liposomes is dehydration-rehydration and no organic solvents are used. 184 4.6 Coacervation 185 In this method, the liquid phase of coating material is separated from a polymeric solution, and the phase is 186 wrapped around the core particles as a uniform layer (F. Gibbs, 1999). It encompasses the dissolving gelling 187 protein and the emulsification of the core compound into the protein. The liquid coating is separated from the 188 polymer solution and is used to cover the material to be encapsulated through controlled physical mixing. It 189 is solidified by thermal, cross-linking or de-solvation methods. Finally, the microcapsuls are obtained by 190 centrifugation or filtration and the results are discrete particles. Coacervation can be simple or complex. The 191\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n7\nformer, contains merely one colloidal solute like gelatin. The latter, is obtained through the usage of a second 192 oppositely charged hydrophilic colloid such as gelatin and gum acacia or gelatin and polysaccharide (F. 193 Gibbs, 1999). (Junyaprasert, Mitrevej, Sinchaipanid, Boonme, & Wurster, 2001) investigated the effect of 194 process variables on microencapsulating vitamin A palmitate via complex coacervation with gelatin and 195 acacia. 196 5. Nanoencapsulation technologies applied on different vitamins 197 According to the recent studies in the field of nanoencapsulation of vitamins, it is expected that in future the 198 novel nanoencapsulation techniques seek to (1) employ naturally occurring food components for encasing 199 bioactives especially vitamins (Chapeau, et al., 2016; David & Livney, 2016; Lee, et al., 2016; Santiago & 200 Castro, 2016), (2) fabricating novel and efficient nanovehicles by the combination of biopolymers, 201 manufacturing nanocomposites, modifying the nanocarriers (Assadpour, Maghsoudlou, Jafari, Ghorbani, & 202 Aalami, 2016; Bochicchio, Barba, Grassi, & Lamberti, 2016; Chapeau, et al., 2016; Lee, et al., 2016; Tan, 203 Feng, Zhang, Xia, & Xia, 2016), (3) exerting novel low energy methods such as, spontaneous emulsification 204 rather than high energy preparation approaches to retain bioactives against harsh processing conditions, 205 decline the surfactant and eliminate the cosurfactant (Assadpour, et al., 2016; Dasgupta, Ranjan, Mundra, 206 Ramalingam, & Kumar, 2016; Mehrnia, Jafari, Makhmal-Zadeh, & Maghsoudlou, 2016) and (4) using novel 207 computational and numerical methods like Monte-Carlo simulations to predict the release profile and 208 optimize targeted delivery of bioactive compounds (Dan, 2016; H. H. Liu, Surawanvijit, Orkoulas, & Cohen, 209 2016; Malik, Genzer, & Hall, 2015). 210 In this section, novel methods for nanoencapsulating vitamins are explained. Table 2 and 3 represents 211 different approaches used for nanoencapsulating hydrophilic and lipophilic vitamins, respectively. 212 Table 2 213 Table 3 214 5.1 Nanoemulsification methods 215 Most prevalent uses of emulsion technology are in aqueous solutions, and nanoemulsions are produced in 216 this medium. Nanoemulsion droplet sizes ranges between 50 to 1000 nm (Sanguansri & Augustin, 2006). 217 There are two ways to prepare nanoemulsions; low energy and high energy techniques such as phase 218 inversion temperature and microfluidization respectively. Nanoemulsions can be used in the liquid state; 219 meanwhile a spray-drying process will be performed to obtain the powder form of the encapsulated material 220 (Jafari, He, & Bhandari, 2007b). Furthermore, it is possible to increase the stability and encapsulation 221 efficiency of the bioactive compounds via multiple emulsions containing a complex of biopolymers 222 (Mohammadi, Jafari, Assadpour, & Esfanjani, 2015). 223 Different vitamins can be encapsulated and transmitted via nanoemulsions (Gonnet, Lethuaut, & Boury, 224 2010; Mohammadi, et al., 2015). For instance, (Cho, Seo, Yim, & Lee, 2013) stated that nanoencapsulation 225 of thiamine dilauryl sulfate (TDS), a vitamin B derivative encased with lecithin as an edible encapsulant, 226\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n8\nrestricted the spore germination of Fusarium oxypansum f.sp. Moreover, this compound obstructed its 227 mycelial growth. 228 There has been some studies in the area of natural surfactants. For instance, (Ozturk, Argin, Ozilgen, & 229 McClements, 2014) encapsulated vitamin D3 in O/W emulsions with quillaja saponin as a natural surfactant. 230 In the experiment bioacessiblity of vitamin D3 declined in the following order: corn oil≈ fish oil ˃ orange oil 231 ˃ mineral oil ˃ medium chain triglycerids (MCT). Long chain triglycerids (corn or fish oil) was considered 232 the optimum compound, which enhance the vitamin bioaccessibility. 233 Double emulsions can be another form of nanoencapsulation of bioactive ingredients (Esfanjani, Jafari, 234 Assadpoor, & Mohammadi, 2015; Mohammadi, et al., 2015). (Bou, Cofrades, & Jiménez-Colmenero, 2014) 235 assessed the physicochemical properties of riboflavin, encapsulated in food-grade W1/O/W2 double 236 emulsions with different types of lipid sources (chia oil, sunflower oil, olive oil or rendered pork backfat). 237 Riboflavin was effectively encapsulated in chia oil at start, nevertheless the double emulsions in rendered 238 pork backfat protected vitamin B2 more efficiently after 8 days at 4 °C. All in all, double emulsions were 239 stable to the stresses that normally exist in the food industry. 240 (Hategekimana, Chamba, Shoemaker, Majeed, & Zhong, 2015; Hategekimana, Masamba, Ma, & Zhong, 241 2015) produced vitamin E- loaded nanocapsuls by octenyl succinic anhydride starches as emulsifiers and 242 wall materials and then stabilized them via spray-drying method. High degree of substitution, low molecular 243 weight and low interfacial tension improved emulsification properties, whereas oxygen permeability and 244 water vapor permeability influenced the film forming characteristics. The degradation profile of vitamin E 245 was best fitted with Weibull model. Overall, low molecular weights formed stable vitamin E nanocapsuls, 246 which can be applied in drug and beverage sector. 247 (Saberi, Fang, & McClements, 2013) fabricated vitamin E-enriched nanoemulsions via spontaneous 248 emulsification. It can be defined as the formation of little oil droplets when an oil/surfactant mixture is 249 titrated in an aqueous solution. When 30% propylene glycol (PG) or 20% ethanol was present in the aqueous 250 phase, the smallest droplets (d<50nm) and highest transparency were acquired. However, Ostwald ripening 251 occurred as nanoemulsions were unstable during storage especially at high temperatures. Undiluted 252 nanoemulsions showed a high and irreversible increase in turbidity upon heating (53°C) for the system with 253 30% PG and 38°C for the one containing 20% ethanol. Considering diluted compounds, a much better 254 thermal stability with a high rate in turbidity at 75.5 °C for both systems. The release criteria of poorly water-255 soluble active vitamin E acetate from oil/water nanoemulsions was reported by (Morais & Burgess, 2014), 256 which used a low energy emulsification method. Nanoemulsions consisted of canola oil, cremophorRH40® 257 and span80®. Dialysis sac and reverse dialysis sac techniques were carried out as well as USP1 dissolution 258 apparatus fitted with dialysis sac adapters to measure the vitamin E release. Micellar solubilization increased 259 vitamin E transport from canola oil to buffer solution; however no concentration active increase in the 260\n1 United States Pharmacopeia\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n9\nnanoemulsion external aqueous phase was seen considering the presence of micelles. (Guttoff, Saberi, & 261 McClements, 2015) prepared vitamin D nanoemulsions through spontaneous emulsification. They 262 investigated the effect of vitamin D and MCT for surfactant to oil ratio, surfactant type (Tween 20,40,60,80 263 and 85) and stirring criteria on the initial particle size of vitamin D. Results showed that small droplet 264 diameters (d<200nm) was produced using Tween at high stirring speeds (800rpm). These systems were 265 unstable to heating (T˃80°C). The thermal stability could be increased by choosing a suitable cosurfactant 266 (sodium dodecyl sulphate). 267 Assadpour, et al., (2016) nano-encapsulated folic acid (vitamin B9) in maltodextrin-whey protein double 268 emulsions via spontaneous emulsification method, which is a low energy technique. They utilized Span 80 as 269 a nonionic surfactant in three phase/surfactant proportions (0.2, 0.6 and 1), moreover the applied folic acid 270 amount was 1.0, 2.0 and 3.0 mg/ml in the dispersed phase. In summary, the formulation containing 3mg/ml 271 folic acid in the 12% dispersed phase and water to surfactant proportion of 0.9 was considered as the 272 optimum sample, thus suggesting that spontaneous technique is beneficial in formulating water in oil 273 nanoemulsions. 274 Dasgupta, et al., (2016) formulated vitamin E acetate nanoemulsions (NE) by edible mustard oil and Tween 275 80 as surfactant. NE was produced via low-energy wash-out technique, in which there is a continuous 276 addition of the water phase to the oil phase and vitamin E acetate. In conclusion, the nanoemulsions 277 (encapsulation efficiency 99.65%) can be used to improve the shelf life of beverages along with their 278 increased antimicrobial and bioavailability characteristics. 279 5.2 Nanoliposomes 280 Hydrophobic/hydrophilic interactions among lipid/lipid and lipid/water interfaces are responsible for the 281 formation of liposomes. Liposomes are formed in single and bilayer arrangements. Lipo-soluble and water-282 soluble vitamins can be entrapped in these nanocarriers for maintaining their stability in different mediums. 283 In a study by (Ma, Kuang, Hao, & Gu, 2009), they inserted vitamin E into nanoliposomes with tea 284 polyphenol (water-soluble). The encapsulation efficiencies reported for hydrophobic and hydrophilic agents 285 were 94% and 50%, respectively. The combined nanoencapsulation of vitamin E with vitamin C has also 286 been carried out (Marsanasco, Márquez, Wagner, Alonso, & Chiaramoni, 2011). Liposome’s structure was 287 influenced by incubation in buffer solution and stomach pH. The higher absorption of the bioactive 288 compound is attributed to the greater bioavailability of vitamin E. 289 (Zhou, et al., 2014) produced a drug delivery system using high methoxyl pectin (HMP) or low methoxyl 290 pectin (LMP) coated with vitamin C liposomes. FTIR and morphology assays demonstrated that the 291 hydrogen binding interactions coated pectin to the vitamin C liposomes. Overall, the skin permeation of 292 vitamin C increased 1.7-fold for HMP-L and 2.1-fold for LMP-L after 1 day respectively, whereas vitamin C 293 nanoliposomes showed a lower number. (N. Liu & Park, 2009) used chitosan-coated nanoparticles made 294\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n10\nfrom phosphatidilecholine (pc) and cholesterol (cho) to encase vitamin C. The nanocapsuls contaning pc:cho 295 ratio 60:40 were promising carriers, which had a loading efficiency about 96.5% and a payload of 46.82%. 296 Tan, et al., (2016) employed composite phospholipid-chitosan to coat the nanoliposomes (chitosomes), 297 which entailed carotenoids, lycopene, ẞ-carotene, lutein and canthaxanthin. The composite covered the 298 liposomes via layer self-assembly deposition method. To sum up, the biopolymer-covered nanoliposomes 299 protected lutein and ẞ-carotene to a greater extent compared to canthaxanthin and lycopene. Considering the 300 arrangement of free lipid molecules at the hydrophilic heads and the non-polar membrane core were 301 enhanced, which directly represents the stability of these biopolymer nanoparticles against undesirable 302 conditions; such as, GI stress, etc. Also, Bochicchio, et al., (2016) loaded various vitamins (vitamin E, 303 vitamin B12 and vitamin D2) via nano liposomes including multilamellar large vesicles (MLVs) and small 304 unilamellar vesicles (SUVs). All in all, great encapsulation efficiencies were achieved by both MLVs 305 (between 72% to 95%) and SUVs (between 56% to 76%). 306 5.3 Nanoprecipitation 307 This method is also called solvent displacement. In this process, the organic internal phase containing the 308 dissolved vitamin is emulsified into the aqueous external phase. The precipitation of polymer from an 309 organic solution and the diffusion of the organic solvent in the aqueous medium is occurred in this technique 310 (Galindo-Rodriguez, Allemann, Fessi, & Doelker, 2004). 311 (Khayata, Abdelwahed, Chehna, Charcosset, & Fessi, 2012) produced vitamin E-loaded nanocapsuls via 312 nanoprecipitation technique at laboratory and pilot-scale. The effect of several formulation variables was 313 investigated on the nanocapsuls properties (mean diameter, zeta potential and entrapment efficiency). The 314 optimized formulation of the vitamin E-loaded nanocapsule at laboratory and pilot-scale had the mean 315 diameter of 165 and 172 nm, respectively with a high entrapment rate (98% and 97%, respectively). 316 (Duclairoir, Orecchioni, Depraetere, & Nakache, 2002) encapsulated vitamin E in the matrix of protein 317 fractions of wheat gluten (gliadins). They co-precipitated aqueous ethanolic solution of vitamin E and gliadin 318 in water. 319 Emulsification-solvent evaporation is an improved sort of solvent evaporation technique which includes 320 emulsification of the polymer solution into an aqueous. Afterwards, the solvent is evaporated and the 321 polymer precipitation remains as the nanoparticles (Reis, Neufeld, Ribeiro, & Veiga, 2006). The size of the 322 particles can be modified by adjusting the stir rate, type and the amount of dispersing substance, viscosity of 323 the phases and temperature. High-speed homogenization and ultrasonication are applied in order to obtain a 324 small particle size (Dehnad, Mirzaei, Emam-Djomeh, Jafari, & Dadashi, 2014). 325 David & Livney, (2016) engaged potato proteins (Patatin, protease inhibitors and other high molecular 326 weight proteins comprising 40%, 50% and 10% of the whole soluble proteins sequentially) as a natural food-327 based material to protect and deliver vitamin D3 (VD) in model beverage solutions. VD was encapsulated 328 within the protein nanoparticles using the liquid antisolvent precipitation method in which two solvents are 329\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n11\nemployed; one is a good solvent for the bioactive, while the other represents poor solvent activity, finally by 330 adding an antisolvent the bioactive compound is precipitated. To sum up, VD- potato proteins nanocomlexes 331 increased the shelf life of the samples and declined the vitamin loss through pasteurization rendering clear 332 and enriched solutions. 333 5.4 Solid lipid nanoparticles (SLNs) 334 It is a nice alternative for nanodispersions. The nanoparticles are produced through congealing. The vitamins 335 are nanoencapsulated in a solid lipid matrix which has a good stability. (Patel, Martin‐Gonzalez, & Fernanda, 336 2012), encapsulated vitamin D2 (ergocalciferol) using SLNs as the carrier. They observed that the 337 concentration of vitamin D2 increased, and enhanced dispersion clarity. SLNs also brought protection to 338 vitamin D2 from oxygen and light. Higher the ergocalciferol loading power, the lower turbidity of the SLN 339 dispersions. (Jenning, Gysler, Schäfer-Korting, & Gohla, 2000) nanoencapsulated vitamin A in SLNs for 340 dermal release. The release kinetic was estimated over a period of 24h via Franz diffusion cells. In the first 6 341 h, Vitamin A-SLN showed controlled release and in longer periods (12-24h), the release rate exceeded the 342 release rate of comparable nanoemulsions. Drug release is caused due to the decline of amorphous regions in 343 the carrier lattice through a polymorphic transition (ẞ´→ẞ). 344 5.5 Cyclodextrins (CDs) 345 Liposoluble vitamins can be encapsulated in cage molecules such as CDs or assemblies formed from 346 micelles-like systems. CDs-vitamin combination enhances molecule apparent solubility but the stability 347 depends on pH and dissolution media structure (Lin, Chean, Ng, Chan, & Ho, 2000). Solubility enhancing 348 effect on vitamin A using these capsuls has been reported, like the increase in solubility of all trans retinoic 349 acid in inclusion complexes considering ẞ-CD and hydroxyl propyl ẞ-CD (Lin, Chean, Ng, Chan, & Ho, 350 2000). Vitamin D has also been encapsulated using this technique, by means of ethanol as a common solvent 351 (Soares, Murhadi, Kurpad, Chan She Ping‐Delfos, & Piers, 2012). 352 5.6 Biopolymer nanoparticles 353 Recently, there have been some studies on nanoencapsulation of food bioactive ingredients including 354 vitamins by nanoparticles made from biopolymers such as milk proteins, gelatin, chitosan, starch and many 355 other natural polymers. For example, (Abbasi, Emam-Djomeh, Mousavi, & Davoodi, 2014) used whey 356 protein isolates (WPI) nanoparticles for encapsulating vitamin D3 and investigated its stability for 7 days in 357 presence of air. According to their results, nanoparticles had a higher content residual of vitamin D compared 358 to the control sample (water, native WPI and denaturized WPI). Dense structures were produced because of 359 the presence of calcium in the particles, therefore inhibition of oxygen diffusion was also observed in 360 particles. These nanoparticles are applicable in the beverage industry. 361 In another study, (Penalva, et al., 2015) exerted casein nanoparticles as a surrounding material for folic acid. 362 Lysine and arginine provided the stability of nanoparticles, eventually the mixture was dried through spray-363 drying. It was observed that the mean size of produced nanoparticles were 150 nm, meanwhile the folic acid 364\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n12\nvalue estimated around 25µg/mg in the nanoparticle. For the in vitro release properties, folic acid exposed 365 gastroresistant characteristics and release was possible under controlled intestinal conditions. Regarding in 366 vivo studies carried out in this project, laboratory animals were orally administered by this vitamin. Overall, a 367 higher serum could be distinguished in animals treated with casein nanoparticles in which the bioavailability 368 assessed to be 50-52% higher than the traditional solution. At the same time, both bioavailability and release 369 profile of the nanoparticles remained unchanged by high hydrostatic pressure treatment. 370 Jiménez-Fernández, et al., (2014) produced chitosan-based nanoparticles as a tool to deliver 371 vitamin C to marine organisms. Zebrafish liver cell-line was chosen for in vitro studies and in vivo 372 studies were done in fish and rotifers to estimate the viable use of nanoencapsulated particles. A 373 significant increase observed in the overall antioxidant capacity of nanoencapsulated-vitamin C in 374 cells, compared to the non-loaded nanoparticles. In post-metamorphic larvae of S. senegalensis 375 nanoparticles entered the intestinal epithelium after 2h. In rotifers fed with vitamin C-376 nanoparticles the level of ascorbic acid raised up to 2-fold in comparison to control groups. 377 (Alishahi, et al., 2011) used chitosan nanoparticles in order to enhance the shelf life and delivery 378 of vitamin C. pH dependency observed in the release of vitamin C, as quick release took place in 379 0.1 M phosphate buffer solution (PBS, pH 7.4), whereas the release was slow in 0.1 M HCl. As a 380 result, the shelf life of vitamin C was increased by this method and in vivo release rate in intestinal 381 tract of rainbow trout was similar to the in vitro one. 382 Lee, et al., (2016) utilized commercial soy protein isolate (SPI) as natural nano-carrier materials, 383 perepared via ultrasonication for 5 minutes, treatment at pH= 12 and using canola oil to protect 384 vitamin D3 against undesirable conditions, especially when exposed to UV rays. Ultimately, 385 retention of 73.5% was achieved using these natural building blocks compared to the non-coated 386 control (5.2%), which highlights the potential of these nano-vehicles to be used in foods and 387 pharmaceutical industry. 388 5.7 Coacervation 389 Coacervation nanoencapsulation technique is based on phase separation because of macromolecules 390 desolvatation. It can get started through environmental changes, which may affect polymer solubility in the 391 solvent, such as; addition of salt or an opposite charged polymer. This process can be adapted to industrial 392 scale (Renard, et al., 2002). (Comunian, Abbaspourrad, Favaro-Trindade, & Weitz, 2014) nanoencapsulated 393 vitamin C via complex coacervation using both gelatin and gum Arabic as encapsulating agents. Low 394 hygroscopicity values were obtained, thus the produced powder could be easily stored and handled. The 395 application and flow of the nanocapsuls were facilitated as they had spherical structures. To summarize, the 396 treatment composed of ratio of 1:1:0.75 of gelatin, gum Arabic and ascorbic acid with 0.025 g/ml of polymer 397 had the best stability at room temperature (20°C). 398\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n13\nChapeau, et al., (2016) used ẞ-lactoglobulin (BLG) and Lactoferrin (LF) co-assemblies to bind vitamin B9 399 (B9). The resulting B9-LF-BLG co-assemblies generated via coacervation and aggregation were thereupon 400 analyzed through compiling screening maps. All in all, B9-LF-BLG coacervates displayed great performance 401 in entrapping vitamin B9 (≈10 mg B9/g protein), showing that natural food components has a great potential 402 to be utilized as biocarriers in designing functional and healthy foods. 403 5.8 Electrospinning and Electrospraying 404 In electrospinning, a polymer solution is provided from a spinneret and produces a droplet at the spinneret 405 exit. Applying an electrical field (103 V/cm), the electric charges will gather on the surface of the droplet. 406 Next, the droplets will be deformed by the electric field and they will form a shape of cone, called the Taylor 407 cone. As the field strength increases, a fluid jet originates under the electric field adjacent to the spinneret tip 408 and moves toward the conductive collector (counter electrode). Whipping and circular movements trigger a 409 fast evaporation of the solvent due to the high surface charge jet under the electric field. After the process, 410 solid thin fibers are acquired in the form of nonwoven mats (Kessick, Fenn, & Tepper, 2004). 411 Electrospraying would be defined liquid atomization applied through electrical forces. The difference 412 between these techniques lies in the solution concentration. With this in mind, for low-concentrated solutions 413 the jet attached to cone is destabilized owing to varicose, then the output is fine particles. On the contrary, if 414 the concentration is high the jet is stabilized and the yield will be elongated fibers by whipping instability 415 procedure (Bhushani & Anandharamakrishnan, 2014). 416 Pérez-Masiá, et al., (2015) successfully applied this technique to nanoencapsulate folic acid, entrapped by 417 whey protein concentrate (WPC) matrix and commercial resistant starch. According to the results, 418 electrospraying yielded smaller particle sizes compared to nanospray-drying. Likewise, WPC capsuls 419 enhanced the bioavailability and stability of folic acid. The answer of this phenomena lies within the 420 interaction between the protein matrix and folic acid which bolsters the stability. Taepaiboon, 421 Rungsardthong, & Supaphol, (2007) encapsulated all-trans vitamin E and retinoic acid via cellulose 422 nanofibers, moreover the encapsulated bioactive compounds showed a gradual release. 423 Wu, Branford-White, Yu, Chatterton, & Zhu, (2011) encapsulated vitamin C and E, using electrospun 424 polyacrylonitrile nanofibers as the wall material. They demonstrated that this technique has a better sustained 425 release behavior considering bioactive compounds. Vitamin A and E were encapsulated via electrospun 426 cellulose acetate nanofibers having a smooth and round cross-sectional morphology (Taepaiboon, et al., 427 2007). (Madhaiyan, Sridhar, Sundarrajan, Venugopal, & Ramakrishna, 2013) investigated producing vitamin 428 B12 loaded polycaprolactone nanofiber with constant release of hydrophilic drug as a transdermal delivery 429 procedure. The drug fibers produced through electrospinning technique were observed with SEM for 430 morphology; moreover pore size measurements, mechanical properties and FTIR experiments were also 431 applied on the nano-fibers. The fiber was plasma treated in different periods and made hydrophilic slowly in 432 order to elevate the vitamin release. Due to the drug release profile in PBS buffer in vitro medium, the 433\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n14\ncyanocobalamin loaded nanofiber considered suitable for transdermal patch. (Sheng, et al., 2013) entrapped 434 vitamin E in silk fibroin (SF) nanofibers. The incorporation of vitamin E improved the protecting ability of 435 SF nanofibrous to protect the skin fibroblast cells against oxidation stress caused by tert-butyl hydroperoxide. 436 These loaded nanofibers, offered an applicative potential for personal skin care, tissue regeneration and the 437 related aspects. 438 5.9 Ionotropic gelation 439 This method is based on polyelectrolytes that form cross links in the presence of ions to produce hydrogel 440 beads termed as gelispheres. Gelispheres can be defined as spherical cross linked hydrophilic polymeric 441 entity showing extensive gelation and swelling in simulated bio-fluids. The release of vitamin is controlled 442 by polymer relaxation in this process. As the drug-loaded polymeric solution enters the aqueous solution of 443 polyvalent cations, the hydrogel beads are formed. Next, a 3-dimensional lattice of ionically crosslinked 444 moiety is formed. Bioactive compounds and vitamins are loaded in to these gelispheres so that their natural 445 structures will not be distorted. 446 Azevedo, Bourbon, Vicente, & Cerqueira, (2014) encapsulated vitamin B2 using alginate/chitosan 447 nanoparticles. The encapsulation efficiency and loading capacity values of the nanoparticles were 55.9±5.6% 448 and 2.2±0.6%, respectively. Release profiles showed that polymeric relaxation was the most common 449 phenomenon in vitamin B2 release. Considering the terms of size and PDI (Polydispersity index), vitamin B2-450 loaded nanoparticles were more stable than the one’s without it. (de Britto, de Moura, Aouada, Mattoso, & 451 Assis, 2012) synthesized nanoparticles containing water-soluble chitosan derivative (N,N,N-trimethyl 452 chitosan, TMC) through ionic gelation with tripolyphosphate (TPP) anions. Three vitamins (B9, B12 and C) 453 were encased by this technique, then zeta potential, morphology and spectroscopy properties were measured. 454 When nanoparticles were loaded with vitamin C, a maximum diameter of 534±20 nm was reached. 455 Moreover, the zeta potential decreased as the vitamins were applied, except vitamin C. They concluded that 456 TMC/TPP nanoparticles are a suitable medium for transporting vitamins in the food sector. 457 6. Characterization methods for nanoencapsulated vitamins 458 The most common ways to determine nanoparticles morphology are cryogenic transmission electron 459 microscopy (cryo-TEM), transmission electron microscopy (TEM), scanning electron microscopy (SEM) 460 and atomic force microscopy (AFM). Dynamic light scattering (DLS) is extensively used by scientists to 461 specify the size distribution of vitamin nanoparticles. Zeta potential is measured via laser Doppler 462 anemometry. This factor gives us information about the stability and size of nanoparticles in the in vitro 463 environment (Garti, 2008). Considering surface modification of the nanoparticles, Fourier transform infrared 464 spectroscopy (FTIR) is an appropriate method to analyze this feature. High pressure liquid chromatography 465 (HPLC) or spectroscopy at defined wavelengths can be used to determine the quantitative characteristics of 466 entrapped vitamins within nanocapsuls (Garti, 2008). 467\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n15\nAs an example, Vilanova & Solans, (2015) characterized vitamin A palmitate (VAP) complexed by ẞ-468 cyclodextrins (ẞ-CDs) molecules through FTIR and UV-Vis spectroscopy. According to the spectroscopy 469 results, as the concentration of ẞ-CDs increased, the solubility of VAP declined continuously, thus a less 470 water-soluble complex will be formed (ultimately two ẞ-CDs molecules encapsulate a unit VAP molecule). 471 For the investigation of functional groups participating in inclusion complexation, FTIR assay was carried 472 out. As a result, at the bands of 3050 and 950 cm-1 (belongs to =CH bond) the double bond was not present 473 showing that the VAP is incorporated within the moiety of =CH section. 474 7. Controlled release of vitamins through nanoencapsulation 475 Degradation of polymeric matrix is responsible for releasing the vitamins (passive release) from 476 micro/nanocapsuls, and dispersing the vitamin throughout the matrix (active release). When the vitamin is 477 released, diffusion of the particles plays an important role in this stage. In this period, the vitamins diffuse in 478 the hydrophilic environment (Dan, 2016). Furthermore, water molecules are dispersed through the 479 nanoparticle matrix. Diffusion rate is closely related to the hydrophilicity of the polymeric matrix. Afterward, 480 the vitamin and the nanocapsuls are eroded gradually (Lamprecht, Schäfer, & Lehr, 2001). Initially the 481 vitamins in the nanoparticles are released fast in reaction to the apt environment (burst effect), followed by a 482 more stationary release rate. The burst effect is advantageous when the high releases strengthen the 483 performance of the active particle or it might be hazardous when a constant release rate is expected. 484 The basic approaches to quantify the release of vitamins are illustrated in Fig 4. The first method (a) uses 485 centrifugation to separate the core material from the nanoparticle suspension; meanwhile the second method 486 (b) uses dialysis or filtration for separation. PBS (phosphate bovine serum) is a common suspension medium, 487 which is applied here. Considering the first method, volume is kept constant by addition of PBS. In the other 488 approach, sample is divided into many sub-samples to study the release profile for the desired period of time. 489 Concentration gradient is kept constant in the second approach for the occurrence of diffusion process. 490 Fig. 3 491 The main factors which influence release profile of vitamins are explained below along with the recent 492 investigations. 493 7.1 Vitamin type and concentration 494 Chemical and physical interactions such as, hydrophilic-hydrophobic interactions, Van der Waals forces, etc. 495 among the vitamin and polymeric matrix influence the release mechanism of the entrapped agent. The 496 amount of the vitamin is an important factor, which controls the release rate. The higher the amount of the 497 vitamin, the faster the release rate becomes. There are two terms to express the amount of entrapped vitamin. 498 First, the vitamin content is attributed to a mass of vitamins in nanoparticles divided by mass of 499 nanoparticles, expressed in %w/w. An ordinary value for the vitamin quantity ranges between 0.5 to 4% w/w 500 for hydrophilic components, and 10 to 15% w/w for hydrophobic components. Second, the entrapment 501\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n16\nefficiency is computed through dividing the content of the vitamin entrapped by theoretical amount of 502 vitamin (the amount first used in nanoparticle formation)(Garti, 2008). 503 Li, et al., (2012) investigated the effects of whey protein-polysaccharide complexes on the controlled release 504 of vitamin B2 and vitamin E in double emulsion medium (W/O/W), besides the employed polysaccharides 505 were low methoxyl pectin (LMP) and -carageenan (KCG). This study underlines the release rate of 506 lipophilic and hydrophilic vitamins as after the coated capsules were exposed to pancreatin at pH= 7.4; the 507 release rate of both vitamins illustrated somehow similar release rates (≈90%) after 6 h, meanwhile the 508 release profile of vitamin B2 was a bit higher than vitamin E and lastly the encapsulation efficiency of 509 vitamin E was higher than vitamin B (66% to 64%). Seidenberger, Siepmann, Bley, Maeder, & Siepmann, 510 (2011) controlled the release profile of multiple vitamins (Nicotinamide, riboflavin 5’- phosphate, pyridoxine 511 hydrochloride, thiamine chloride hydrochloride, riboflavin and thiamine nitrate) via the variation of total 512 vitamin concentration. They enhanced the whole vitamin concentration from 10 to 16% and observed that 513 diffusivity was directly proportional to the total vitamin content. 514 7.2 Biopolymer (variety, copolymer ratio, MW) 515 Various polymers have been synthesized as nanoparticles. Chitosan, dextran, albumin, pullulan, poly lactic 516 acid (PLA), poly ethyl oxide (PEO), poly caprolactone, poly 3-hydroxybutyrate are typical examples of the 517 natural and synthetic polymers used in nanoencapsulation of vitamins. The break-down of these 518 nanoparticles affect the vitamin release profile. For instance, poly lactic acid, poly lactide-co-glycolide acid 519 (PLGA) are nanoparticles which seem to degrade homogenously, while no autocatalysis takes place 520 (Lemarchand, Couvreur, Vauthier, Costantini, & Gref, 2003; Y.-P. Li, et al., 2001; Zweers, Engbers, 521 Grijpma, & Feijen, 2006). 522 The hydrophilic-hydrophobic ratio of the polymer plays a key role in the release of the entrapped vitamin. 523 For example, PLGA is a hydrophobic complex, consisted of lactide and glycolide monomers. The 524 hydrophilic balance of the PLGA can be changed through altering the copolymer ratio (The most prevalent 525 PLGA molar ratios are: 50:50, 75:25 and 85:15). Thus, the degradation pace will be altered (Bala, Hariharan, 526 & Kumar, 2004). The more hydrophobic the polymer, the stronger interactions between the polymer and 527 bioactive compounds are, so the release process will happen slower. Also, the molecular weight of the 528 polymer affects the release profile, which ranges between a few thousands Da to above 100 000 Da. The 529 higher the molecular weight, the slower the vitamin is released. 530 To highlight the effect of biopolymer in the release of vitamins, Messaoud, et al., (2016) analyzed the effect 531 of alginate nanocapsules coated with shellac in three different concentrations (1,5 and 10% w/w) and two 532 various coating mechanisms including Ca2+ reticulation and acid development on release properties of 533 vitamin B2. As a result, coated nanocapsules displayed pH-dependant release trend, particularly after binding 534 to calcium cations. By declining pH, the release rate of coated nanovehicles decreased, moreover the 5% w/w 535\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n17\nshellac concentration created the best results. However, using the 1% w/w the coating polymer became labile 536 and the 10% w/w caused the alginate membrane to be degraded. 537 7.3 Nanoparticle size 538 Nanoparticle size also influences the release process. As the nanoparticles get bigger, their dissociation 539 occurs more slowly. Moreover, the initial burst phase is declined with the slow release according to the slow 540 nanoparticle degradation (Prabha, Zhou, Panyam, & Labhasetwar, 2002). Microparticles are released slower 541 than the nanoparticles according to lower surface toward nanoparticles (Bala, et al., 2004; Panyam & 542 Labhasetwar, 2003). 543 Kulkarni & Feng, (2013) investigated the effects of nanoparticle size and vitamin E TGPS coating on the 544 release rate and cellular uptake of the nanoparticles across the GI via in vivo and in vitro assays. They 545 reported that nanoparticle size and the coating substance can considerably alter the nanopartilces release rate 546 and biodistribution. The prepared commercial fluorescent nanoparticles size ranged from 20nm to 500nm, as 547 a result the distribution of nanoparticles were 50nm>200nm>500nm>100nm>25nm, which approves the 548 aforementioned information that as nanoparticles get smaller, the release rate and distribution will become 549 higher. All in all, the 100 and 200nm TGPS-coated nanoparticles efficiently delivered the drugs in the GI 550 cells. 551 7.4 Environmental circumstances (pH, temperature and release medium) 552 Environmental conditions alter the release rate and diffusion process. The polymer´s action changes 553 according to the factors like; pH, temperature or other parameters. As an example, poly ortho esters are 554 stable at higher pH (alkaline), while it is disintegrated at acidic pH. Physiological pH is around 7; however, 555 organelles have a distinct pH. Endosomes are more acidic, and lysosomes pH is around 5. Exposing to this 556 pH, the degradation mechanism or polymer configuration initiate, thus the entrapped vitamin will be 557 released. Temperature can also affect the release of the entrapped vitamins. Poly butyl methacrylate and poly 558 N-isopropylacrylamide are some examples of temperature release components (Chung et al., 2000). 559 Recently, Yang, Decker, Xiao, & McClements, (2015) exerted simulated small intestinal fluid (SSIF) 560 medium to examine the release rate and bioaccessibility of vitamin E trapped in O/W emulsions. Applying 561 the medium chain triacylglycerol (MCT) and long chain triacylglycerol (LCT), they noticed that the addition 562 of calcium cations to LCT emulsions will increase the release rate of vitamin E in the prepared medium. 563 Moreover, the degradation rate was higher for MCT-emulsions compared to LCT-emulsions, which 564 highlights the importance of environmental conditions and the encapsulant structure on the release rate. 565 7.5 Complexation 566 A decrease in diffusion may result as a response to the polymer and vitamin conjugation, thus the release of 567 the component can hardly take place. As an example, Pereira, et al., (2016) formulated nanoencapsulated 568 vitamin E conjugated with polymeric films including Aloe vera extract, hyaluronic acid, polyethyleneoxide, 569 hyaluronic acid and polyvinyl alcohol to heal skin wounds. To sum up, the polymeric films and their 570\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n18\nconjugation effects lead to the prolonged release of vitamin E for the purpose of treating damaged skin 571 tissue. 572 8. Safety regulations and risks of nanoencapsulated vitamins 573 Considering food safety, FDA has confirmed the approaches related to the nanotechnology-based food 574 components for mass production (Chau, et al., 2007). However, questions are being posed that the increased 575 bioavailability, uptake and modified biokinetics of the nanosized vitamins might be hazardous to the 576 biological system. It is assumed that biodegradable natural materials which are used for nanoencapsulation 577 are considered low-risk compared to synthesized polymeric nanocapsuls. Until now, ambiguities on 578 consuming nano-scale food materials still exist, besides their effects on human health and environment needs 579 to be further analyzed (Dowling, 2004). 580 Still, there is no certain legislation in which nanomaterials (especially encased vitamins) in food industry are 581 markedly addressed; nevertheless agencies and government insist that current legislations made by them 582 ensure the safety of nano-food products (Amenta, et al., 2015). 583 8.1 An overview of nano regulations in different countries 584 In 2011, a guidance document entitled “Guidance for the risk assessment of the application of nanoscience 585 and nanotechnologies in the food and feed chain” was prepared by The European Food Safety Authority 586 (ESFA). In essence, this guidance provides as assessment for the risks of employing nanomaterials in food 587 products. Nevertheless, considering the physico-chemical properties of the nanomaterials, these minute 588 particles are also needed to be analyzed in five stages: (a) When prepared; (b) for the usage in food product; 589 (c) within the food network; (d) In the toxicity assays; (e) inside the biological fluids and cells. 590 Another important factor, which should be considered, is the interactions occurred between nanomaterials 591 and food structure. Regarding the catalytic function of the nanomaterials, radical oxygens or photoreactions 592 might be formed, thus these factors should be carefully characterized within the nanofood products. 593 According to the EU principle suggested in December 2011 (Amenta, et al., 2015), engineered nanomaterials 594 (ENM) should be mentioned in the label of nano-food products. This legislation was considered to be exerted 595 till in December 2014. Regarding article 2 from this legislation, ENMs are considered to be 100nm or less in 596 one or more dimensions either inside or at the surface moreover aggregates or agglomerates above the size of 597 100nm, which represent the nano characteristics, are also referred as ENMs. 598 The US Food and Drug Administration (FDA) believes that emerging nano-food products can be regulated 599 under its authorities, nevertheless there is not a delicate principle attributed to the nanomaterials within food 600 industry. On the other hand, this organization has prepared a guidance for the manufacturers entitled “Draft 601 Guidance for Industry” regarding the safety and regulatory issues in novel food industry technologies (FDA, 602 2011). This definition of nanomaterials described by this draft guidance is mentioned below: 603 • Agents or products lying within the nanoscale range at least in one dimension (from 1 to 100nm). 604\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n19\n• Agents or products that reveal physical, chemical and biological characteristics related to the 605 nanomaterials, albeit they are not nano-sized. 606 Besides, the guidance has defined some responsibilities for the manufacturers, which are as follows: 607 • Monitor the changes being exerted to the food materials; such as, physicochemical properties and 608 impurities. 609 • Evaluate the safety of food products after their modifications. 610 • Submit a regulatory assessment to US FDA 611 • Specify a regulatory issue for the consumption of the novel food product 612 Regarding the mentioned guidance, USA FDA insists that the current legislations are adequate for evaluating 613 nanomaterials safety, moreover the organization accentuates that all manufactured nano-food products 614 should be approved in accordance with the principles present in their guidance. 615 The regulatory organization of other countries including Australia and New Zealand (FSANZ), and Korea 616 (MFDS) believe that food products treated with nanomaterials should be evaluated through safety 617 experiments before releasing in the food market and they have published some related guidelines too. 618 8.2 Nanoparticles fate in the digestive system 619 In general, after the oral administration of the nanoparticles, three options are considered for both the vitamin 620 and the nanocapsule/matrix (Fig 4): 621 1. The nanoparticle plus the vitamin are released in the gastrointestinal (GI) tract and full digestion with 622 absorbance is carried out. At the same time, the surfactants used in the complex should be assessed through 623 safety assays. 624 2. Nanovehicles will be broken down partially; therefore the encapsulated vitamin is released slightly. 625 Moreover, conjugates will be formed between the residual nanovehicles and the vitamin, hence different 626 traits and biokinetic behavior is expected from these conjugates. Another possible risk is that these unknown 627 conjugates may translocate to the other organs because of their miniature size. It is possible that these 628 compounds may act as allergens and trigger immunogenic responses in human body. With this intention, 629 further studies need to be performed for evaluating the absorption, distribution, metabolism and excretion 630 (ADME) data regarding the nonovehicle-vitamin complexes. For example, gelatin nanoparticles are formed 631 via cross-linking which cause immunogenic responses and the content of antibodies will rise in this situation. 632 As stated before, immunological concerns are more likely to happen in a multicomponent formulation rather 633 than a uniform structure. 634 3. The nonovehicle is resistant to digestion, and then vitamins are not released in the GI tract. Here two 635 options are assumed: 636 a. The nanoparticle plus the core material is thoroughly excreted from the GI tract. However, this is not a 637 suitable option; hence the engineered nanomaterial would not be commercially useful in the food sector 638 (Sabliov, 2015). 639\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n20\nb. Due to nanosize scale, the nanovehicle and entrapped vitamin can pass the biological barriers in the 640 intestine and enter the circulatory system. This is where immunologic and toxicokinetics assays may be 641 crucial. When a nanoengineered carrier is applied in the food sector, investigations must be done to evaluate 642 its biodistrubution properties, toxicological effects and improper alterations in the nanoengineered material 643 properties (Sabliov, 2015). 644 To sum up, a precise design for nanovehicles can mask the safety problems to a great extent and the safety 645 can be assessed in a straightforward approach. Moreover, being conscious in full features of safety concerns 646 are the key to a better design and to make commercially nanodelivery systems possible. 647 Fig. 4 648 9. Conclusions and future trends 649 Nanoencapsulation of vitamins with different techniques is expected to be a crucial field of research in the 650 following years. By entrapping several vitamins in the nanocapsuls, a synergistic effect can be achieved that 651 enriches human food. Techniques like nanoemulsification, coacervation, nanoprecipitation, nanoliposomes 652 and solvent evaporation are enduring methods for nanoencapsulating not only vitamins but also other 653 ingredients. Furthermore, solvent evaporation and nanoprecipitation remains to be exclusive approaches to 654 encapsulate lipophilic vitamins. Nonetheless, all these techniques require suitable drying methods in order to 655 produce nanoencapsulates in the powder form. Today, spray-drying and freeze drying are widely used as 656 drying methods in order to nanoencapsulate the bioactive materials, especially vitamins. The disadvantages 657 of freeze drying and spray-drying are the high costs and changes needed for retaining the nanoparticle size, 658 respectively. Therefore, special apparatuses are required to produce the nano-sized powders. Besides, each 659 encapsulation technique has its own operating characteristics that influence the final nano product. Most of 660 the nanoencapsulated products have represented excellent bioavailability. The release of the vitamins is 661 considerably related to the nanoparticle size among the other physical features, thus many scientists are 662 trying to decline the size of the nanoparticles due to the increase in the surface and better absorption in the 663 epithelial cells. More work need to be done on carefully designing the nanoparticle to interact in the 664 appropriate conditions (i.e. pH, temperature). Challenging questions might come up with this end; like 665 synthesizing novel nanopolymers for optimizing the delivery process. Furthermore, the safety of vitamin 666 nanoencapsulation in food needs further investigation. It includes the complicated interactions among 667 nanoparticles and the cellular system. Finally, the process of the delivery in the reaction site needs to be 668 carefully studied. 669 References 670\nAbbasi, A., Emam-Djomeh, Z., Mousavi, M. A. E., & Davoodi, D. (2014). Stability of vitamin D 3 encapsulated 671 in nanoparticles of whey protein isolate. Food Chemistry, 143, 379-383. 672 Alishahi, A., Mirvaghefi, A., Tehrani, M., Farahmand, H., Shojaosadati, S., Dorkoosh, F., & Elsabee, M. Z. 673 (2011). Shelf life and delivery enhancement of vitamin C using chitosan nanoparticles. Food 674 Chemistry, 126, 935-940. 675\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n21\nAmenta, V., Aschberger, K., Arena, M., Bouwmeester, H., Moniz, F. B., Brandhoff, P., Gottardo, S., Marvin, 676 H. J., Mech, A., & Pesudo, L. Q. (2015). Regulatory aspects of nanotechnology in the agri/feed/food 677 sector in EU and non-EU countries. Regulatory Toxicology and Pharmacology, 73, 463-476. 678 Assadpour, E., Maghsoudlou, Y., Jafari, S.-M., Ghorbani, M., & Aalami, M. (2016). Optimization of Folic Acid 679 Nano-emulsification and Encapsulation by Maltodextrin-Whey Protein Double Emulsions. 680 International journal of biological macromolecules. 681 Azevedo, M. A., Bourbon, A. I., Vicente, A. A., & Cerqueira, M. A. (2014). Alginate/chitosan nanoparticles for 682 encapsulation and controlled release of vitamin B 2. International journal of biological 683 macromolecules, 71, 141-146. 684 Bala, I., Hariharan, S., & Kumar, M. R. (2004). PLGA nanoparticles in drug delivery: the state of the art. 685 Critical Reviews™ in Therapeutic Drug Carrier Systems, 21. 686 Bhushani, J. A., & Anandharamakrishnan, C. (2014). Electrospinning and electrospraying techniques: 687 Potential food based applications. Trends in Food Science & Technology, 38, 21-33. 688 Bochicchio, S., Barba, A. A., Grassi, G., & Lamberti, G. (2016). Vitamin delivery: Carriers based on 689 nanoliposomes produced via ultrasonic irradiation. LWT-Food Science and Technology. 690 Bou, R., Cofrades, S., & Jiménez-Colmenero, F. (2014). Physicochemical properties and riboflavin 691 encapsulation in double emulsions with different lipid sources. LWT-Food Science and Technology, 692 59, 621-628. 693 Boyle, S., & Chang, K.-T. (1999). Powder composed of particles consisting of an oleophilic substance 694 encapsulated in a water soluble cellulose polymer; for high potency, dry and free-flowing vitamin 695 powders. In: Google Patents. 696 Chapeau, A.-L., Tavares, G. M., Hamon, P., Croguennec, T., Poncelet, D., & Bouhallab, S. (2016). 697 Spontaneous co-assembly of lactoferrin and β-lactoglobulin as a promising biocarrier for vitamin 698 B9. Food Hydrocolloids, 57, 280-290. 699 Chau, C.-F., Wu, S.-H., & Yen, G.-C. (2007). The development of regulations for food nanotechnology. Trends 700 in Food Science & Technology, 18, 269-280. 701 Cho, J. S., Seo, Y. C., Yim, T. B., & Lee, H. Y. (2013). Effect of nanoencapsulated vitamin b1 derivative on 702 inhibition of both mycelial growth and spore germination of Fusarium oxysporum f. sp. raphani. 703 International journal of molecular sciences, 14, 4283-4297. 704 Chung, J.E., Yokoyama, M., Okano, T., (2000). Inner core segment design for drug delivery control of 705 thermo-responsive polymeric micelles. Journal of Controlled Release 65(1), 93-103. 706 Comunian, T. A., Abbaspourrad, A., Favaro-Trindade, C. S., & Weitz, D. A. (2014). Fabrication of solid lipid 707 microcapsules containing ascorbic acid using a microfluidic technique. Food Chemistry, 152, 271-708 275. 709 Dan, N. (2016). Transport and release in nano-carriers for food applications. Journal of Food Engineering, 710 175, 136-144. 711 Danino, D., Livney, Y. D., Ramon, O., Portnoy, I., & Cogan, U. (2014). Beta-casein assemblies for enrichment 712 of food and beverages and methods of preparation thereof. In: Google Patents. 713 Dasgupta, N., Ranjan, S., Mundra, S., Ramalingam, C., & Kumar, A. (2016). Fabrication of Food grade Vitamin 714 E nanoemulsion by low energy approach, characterization and its application. International Journal 715 of Food Properties, 19, 700-708. 716 David, S., & Livney, Y. D. (2016). Potato protein based nanovehicles for health promoting hydrophobic 717 bioactives in clear beverages. Food Hydrocolloids, 57, 229-235. 718 de Britto, D., de Moura, M. R., Aouada, F. A., Mattoso, L. H., & Assis, O. B. (2012). N, N, N-trimethyl chitosan 719 nanoparticles as a vitamin carrier system. Food Hydrocolloids, 27, 487-493. 720 Dehnad, D., Mirzaei, H., Emam-Djomeh, Z., Jafari, S.-M., & Dadashi, S. (2014). Thermal and antimicrobial 721 properties of chitosan–nanocellulose films for extending shelf life of ground meat. Carbohydrate 722 polymers, 109, 148-154. 723 Desai, K., & Park, H. (2005). Encapsulation of vitamin C in tripolyphosphate cross-linked chitosan 724 microspheres by spray drying. Journal of Microencapsulation, 22, 179-192. 725\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n22\nDesobry, S., Netto, F., & Labuza, T. (1999). INFLUENCE of MALTODEXTRIN SYSTEMS ATAN EQUIVALENT 726 25DE ON ENCAPSULATED β-CAROTENE LOSS DURING STORAGE. Journal of food processing and 727 preservation, 23, 39-55. 728 Dowling, A. P. (2004). Development of nanotechnologies. Materials Today, 7, 30-35. 729 Duclairoir, C., Orecchioni, A., Depraetere, P., & Nakache, E. (2002). α-Tocopherol encapsulation and in vitro 730 release from wheat gliadin nanoparticles. Journal of Microencapsulation, 19, 53-60. 731 ESFA. (2011). Guidance for the risk assessment of the application of nanoscience and nanotechnologies in 732 the food and feed chain. In. 733 Esfanjani, A. F., Jafari, S. M., Assadpoor, E., & Mohammadi, A. (2015). Nano-encapsulation of saffron extract 734 through double-layered multiple emulsions of pectin and whey protein concentrate. Journal of 735 Food Engineering, 165, 149-155. 736 F. Gibbs, S. K., Inteaz Alli, Catherine N. Mulligan, Bernard. (1999). Encapsulation in the food industry: a 737 review. International Journal of Food Sciences and Nutrition, 50, 213-224. 738 Fathima, S. J., Fathima, I., Abhishek, V., & Khanum, F. (2016). Phosphatidylcholine, an edible carrier for 739 nanoencapsulation of unstable thiamine. Food Chemistry, 197, 562-570. 740 FDA, U. (2011). Draft guidance for industry: Assessing the effects of significant manufacturingprocess 741 chances, including emerging technologies, on the safety and regulatory status of food ingredients 742 and food contact substances, including food ingredients that are color additives. In. 743 Galindo-Rodriguez, S., Allemann, E., Fessi, H., & Doelker, E. (2004). Physicochemical parameters associated 744 with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation 745 methods. Pharmaceutical research, 21, 1428-1439. 746 Garti, N. (2008). Delivery and controlled release of bioactives in foods and nutraceuticals: Elsevier. 747 Gonnet, M., Lethuaut, L., & Boury, F. (2010). New trends in encapsulation of liposoluble vitamins. Journal of 748 Controlled Release, 146, 276-290. 749 Gutiérrez, F. J., Albillos, S. M., Casas-Sanz, E., Cruz, Z., García-Estrada, C., García-Guerra, A., García-Reverter, 750 J., García-Suárez, M., Gatón, P., & González-Ferrero, C. (2013). Methods for the nanoencapsulation 751 of β-carotene in the food sector. Trends in Food Science & Technology, 32, 73-83. 752 Guttoff, M., Saberi, A. H., & McClements, D. J. (2015). Formation of vitamin D nanoemulsion-based delivery 753 systems by spontaneous emulsification: factors affecting particle size and stability. Food Chemistry, 754 171, 117-122. 755 Hategekimana, J., Chamba, M. V., Shoemaker, C. F., Majeed, H., & Zhong, F. (2015). Vitamin E 756 nanoemulsions by emulsion phase inversion: Effect of environmental stress and long-term storage 757 on stability and degradation in different carrier oil types. Colloids and Surfaces A: Physicochemical 758 and Engineering Aspects. 759 Hategekimana, J., Masamba, K. G., Ma, J., & Zhong, F. (2015). Encapsulation of vitamin E: Effect of 760 physicochemical properties of wall material on retention and stability. Carbohydrate polymers, 124, 761 172-179. 762 Hickey, S. (2009). Vitamin C: the Real Story: The Remarkable and Controversial Healing Factor: Easyread 763 Comfort Edition: ReadHowYouWant. com. 764 Jafari, S. M., He, Y., & Bhandari, B. (2007a). Encapsulation of nanoparticles of d-limonene by spray drying: 765 role of emulsifiers and emulsifying techniques. Drying Technology, 25, 1069-1079. 766 Jafari, S. M., He, Y., & Bhandari, B. (2007b). Optimization of nano-emulsions production by 767 microfluidization. European Food Research and Technology, 225, 733-741. 768 Jenning, V., Gysler, A., Schäfer-Korting, M., & Gohla, S. H. (2000). Vitamin A loaded solid lipid nanoparticles 769 for topical use: occlusive properties and drug targeting to the upper skin. European Journal of 770 Pharmaceutics and Biopharmaceutics, 49, 211-218. 771 Jiménez-Fernández, E., Ruyra, A., Roher, N., Zuasti, E., Infante, C., & Fernández-Díaz, C. (2014). 772 Nanoparticles as a novel delivery system for vitamin C administration in aquaculture. Aquaculture, 773 432, 426-433. 774\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n23\nJunyaprasert, V. B., Mitrevej, A., Sinchaipanid, N., Boonme, P., & Wurster, D. E. (2001). Effect of process 775 variables on the microencapsulation of vitamin A palmitate by gelatin-acacia coacervation. Drug 776 Development and Industrial Pharmacy, 27, 561-566. 777 Kessick, R., Fenn, J., & Tepper, G. (2004). The use of AC potentials in electrospraying and electrospinning 778 processes. Polymer, 45, 2981-2984. 779 Khayata, N., Abdelwahed, W., Chehna, M., Charcosset, C., & Fessi, H. (2012). Preparation of vitamin E 780 loaded nanocapsules by the nanoprecipitation method: from laboratory scale to large scale using a 781 membrane contactor. International journal of pharmaceutics, 423, 419-427. 782 Kirby, C., Whittle, C., Rigby, N., Coxon, D., & Law, B. (1991). Stabilization of ascorbic acid by 783 microencapsulation in liposomes. International journal of food science & technology, 26, 437-449. 784 Kulkarni, S. A., & Feng, S.-S. (2013). Effects of particle size and surface modification on cellular uptake and 785 biodistribution of polymeric nanoparticles for drug delivery. Pharmaceutical research, 30, 2512-786 2522. 787 Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001). Size-dependent bioadhesion of micro-and nanoparticulate 788 carriers to the inflamed colonic mucosa. Pharmaceutical research, 18, 788-793. 789 Lee, H., Yildiz, G., dos Santos, L., Jiang, S., Andrade, J., Engeseth, N., & Feng, H. (2016). Soy protein nano-790 aggregates with improved functional properties prepared by sequential pH treatment and 791 ultrasonication. Food Hydrocolloids, 55, 200-209. 792 Lemarchand, C., Couvreur, P., Vauthier, C., Costantini, D., & Gref, R. (2003). Study of emulsion stabilization 793 by graft copolymers using the optical analyzer Turbiscan. International journal of pharmaceutics, 794 254, 77-82. 795 Leonard, S. W., Good, C. K., Gugger, E. T., & Traber, M. G. (2004). Vitamin E bioavailability from fortified 796 breakfast cereal is greater than that from encapsulated supplements. The American journal of 797 clinical nutrition, 79, 86-92. 798 Li, B., Jiang, Y., Liu, F., Chai, Z., Li, Y., Li, Y., & Leng, X. (2012). Synergistic effects of whey protein–799 polysaccharide complexes on the controlled release of lipid-soluble and water-soluble vitamins in 800 W1/O/W2 double emulsion systems. International journal of food science & technology, 47, 248-801 254. 802 Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001). 803 PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. 804 Journal of Controlled Release, 71, 203-211. 805 Lin, H., Chean, C., Ng, Y., Chan, S., & Ho, P. (2000). 2-hydroxypropyl-beta-cyclodextrin increases aqueous 806 solubility and photostability of all-trans-retinoic acid. Journal of clinical pharmacy and therapeutics, 807 25, 265-269. 808 Liu, H. H., Surawanvijit, S., Orkoulas, G., & Cohen, Y. (2016). Modeling aggregation and size distribution of 809 nanoparticles with Monte Carlo simulation. Proceedings of NSTI-NanoTech 2010, 3, 532-534. 810 Liu, N., & Park, H.-J. (2009). Chitosan-coated nanoliposome as vitamin E carrier. Journal of 811 Microencapsulation, 26, 235-242. 812 Ma, Q., Kuang, Y., Hao, X., & Gu, N. (2009). Preparation and characterization of tea polyphenols and vitamin 813 E loaded nanoscale complex liposome. Journal of nanoscience and nanotechnology, 9, 1379-1383. 814 Madhaiyan, K., Sridhar, R., Sundarrajan, S., Venugopal, J. R., & Ramakrishna, S. (2013). Vitamin B 12 loaded 815 polycaprolactone nanofibers: a novel transdermal route for the water soluble energy supplement 816 delivery. International journal of pharmaceutics, 444, 70-76. 817 Malik, R., Genzer, J., & Hall, C. K. (2015). Proteinlike copolymers as encapsulating agents for small-molecule 818 solutes. Langmuir, 31, 3518-3526. 819 Marsanasco, M., Márquez, A. L., Wagner, J. R., Alonso, S. d. V., & Chiaramoni, N. S. (2011). Liposomes as 820 vehicles for vitamins E and C: An alternative to fortify orange juice and offer vitamin C protection 821 after heat treatment. Food Research International, 44, 3039-3046. 822\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n24\nMehrnia, M.-A., Jafari, S.-M., Makhmal-Zadeh, B. S., & Maghsoudlou, Y. (2016). Crocin loaded nano-823 emulsions: Factors affecting emulsion properties in spontaneous emulsification. International 824 journal of biological macromolecules, 84, 261-267. 825 Messaoud, G. B., Sánchez-González, L., Probst, L., Jeandel, C., Arab-Tehrany, E., & Desobry, S. (2016). 826 Physico-chemical properties of alginate/shellac aqueous-core capsules: Influence of membrane 827 architecture on riboflavin release. Carbohydrate polymers, 144, 428-437. 828 Mohammadi, A., Jafari, S. M., Assadpour, E., & Esfanjani, A. F. (2015). Nano-encapsulation of olive leaf 829 phenolic compounds through WPC–pectin complexes and evaluating their release rate. 830 International journal of biological macromolecules. 831 Morais, J. M., & Burgess, D. J. (2014). In vitro release testing methods for vitamin E nanoemulsions. 832 International journal of pharmaceutics, 475, 393-400. 833 Neethirajan, S., & Jayas, D. S. (2011). Nanotechnology for the food and bioprocessing industries. Food and 834 bioprocess technology, 4, 39-47. 835 Ozturk, B., Argin, S., Ozilgen, M., & McClements, D. J. (2014). Formation and stabilization of nanoemulsion-836 based vitamin E delivery systems using natural surfactants: Quillaja saponin and lecithin. Journal of 837 Food Engineering, 142, 57-63. 838 Panyam, J., & Labhasetwar, V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and 839 tissue. Advanced drug delivery reviews, 55, 329-347. 840 Patel, M. R., Martin-Gonzalez, S., & Fernanda, M. (2012). Characterization of ergocalciferol loaded solid lipid 841 nanoparticles. Journal of food science, 77, N8-N13. 842 Penalva, R., Esparza, I., Agüeros, M., Gonzalez-Navarro, C. J., Gonzalez-Ferrero, C., & Irache, J. M. (2015). 843 Casein nanoparticles as carriers for the oral delivery of folic acid. Food Hydrocolloids, 44, 399-406. 844 Pereira, G. G., Detoni, C. B., Balducci, A. G., Rondelli, V., Colombo, P., Guterres, S. S., & Sonvico, F. (2016). 845 Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the 846 management of skin wounds. European Journal of Pharmaceutical Sciences. 847 Pérez-Masiá, R., López-Nicolás, R., Periago, M. J., Ros, G., Lagaron, J. M., & López-Rubio, A. (2015). 848 Encapsulation of folic acid in food hydrocolloids through nanospray drying and electrospraying for 849 nutraceutical applications. Food Chemistry, 168, 124-133. 850 Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002). Size-dependency of nanoparticle-mediated 851 gene transfection: studies with fractionated nanoparticles. International journal of pharmaceutics, 852 244, 105-115. 853 Reis, C. P., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006). Nanoencapsulation I. Methods for preparation of 854 drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine, 2, 8-855 21. 856 Renard, D., Robert, P., Lavenant, L., Melcion, D., Popineau, Y., Gueguen, J., Duclairoir, C., Nakache, E., 857 Sanchez, C., & Schmitt, C. (2002). Biopolymeric colloidal carriers for encapsulation or controlled 858 release applications. International journal of pharmaceutics, 242, 163-166. 859 Risch, S. J., & Reineccius, G. (1995). Encapsulation and controlled release of food ingredients. In ACS 860 symposium series (USA): American Chemical Society. 861 Saberi, A. H., Fang, Y., & McClements, D. J. (2013). Fabrication of vitamin E-enriched nanoemulsions by 862 spontaneous emulsification: Effect of propylene glycol and ethanol on formation, stability, and 863 properties. Food Research International, 54, 812-820. 864 Sabliov, M. C., Chen,H., & Yada, R. Y. (2015). Nanotechnology and functional foods: Effective delivery of 865 bioactive ingredients. USA: John Wiley & sons. 866 Sanguansri, P., & Augustin, M. A. (2006). Nanoscale materials development–a food industry perspective. 867 Trends in Food Science & Technology, 17, 547-556. 868 Santiago, L. G., & Castro, G. R. (2016). Novel technologies for the encapsulation of bioactive food 869 compounds. Current Opinion in Food Science. 870\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n25\nSeidenberger, T., Siepmann, J., Bley, H., Maeder, K., & Siepmann, F. (2011). Simultaneous controlled vitamin 871 release from multiparticulates: Theory and experiment. International journal of pharmaceutics, 872 412, 68-76. 873 Semo, E., Kesselman, E., Danino, D., & Livney, Y. D. (2007). Casein micelle as a natural nano-capsular vehicle 874 for nutraceuticals. Food Hydrocolloids, 21, 936-942. 875 Sheng, X., Fan, L., He, C., Zhang, K., Mo, X., & Wang, H. (2013). Vitamin E-loaded silk fibroin nanofibrous 876 mats fabricated by green process for skin care application. International journal of biological 877 macromolecules, 56, 49-56. 878 Shi, X.-Y., & Tan, T.-W. (2002). Preparation of chitosan/ethylcellulose complex microcapsule and its 879 application in controlled release of Vitamin D 2. Biomaterials, 23, 4469-4473. 880 Soares, M., Murhadi, L., Kurpad, A., Chan She Ping-Delfos, W., & Piers, L. (2012). Mechanistic roles for 881 calcium and vitamin D in the regulation of body weight. Obesity reviews, 13, 592-605. 882 Taepaiboon, P., Rungsardthong, U., & Supaphol, P. (2007). Vitamin-loaded electrospun cellulose acetate 883 nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E. 884 European Journal of Pharmaceutics and Biopharmaceutics, 67, 387-397. 885 Tan, C., Feng, B., Zhang, X., Xia, W., & Xia, S. (2016). Biopolymer-coated liposomes by electrostatic 886 adsorption of chitosan (chitosomes) as novel delivery systems for carotenoids. Food Hydrocolloids, 887 52, 774-784. 888 Van Hasselt, P., Janssens, G., Slot, T., Van der Ham, M., Minderhoud, T., Talelli, M., Akkermans, L., Rijcken, 889 C., & Van Nostrum, C. (2009). The influence of bile acids on the oral bioavailability of vitamin K 890 encapsulated in polymeric micelles. Journal of Controlled Release, 133, 161-168. 891 Vilanova, N., & Solans, C. (2015). Vitamin A Palmitate–β-cyclodextrin inclusion complexes: Characterization, 892 protection and emulsification properties. Food Chemistry, 175, 529-535. 893 Wang, R., MacGillivray, B. C., & Macartney, D. H. (2009). Stabilization of the base-off forms of vitamin B12 894 and coenzyme B12 by encapsulation of the α-axial 5, 6-dimethylbenzimidazole ligand with cucurbit 895 [7] uril. Dalton Transactions, 3584-3589. 896 Wegmüller, R., Zimmermann, M. B., Bühr, V. G., Windhab, E. J., & Hurrell, R. F. (2006). Development, 897 stability, and sensory testing of microcapsules containing iron, iodine, and vitamin A for use in food 898 fortification. Journal of food science, 71, S181-S187. 899 Weiss, J., Takhistov, P., & McClements, D. J. (2006). Functional materials in food nanotechnology. Journal of 900 food science, 71, R107-R116. 901 Wildman, R. E., Wildman, R., & Wallace, T. C. (2006). Handbook of nutraceuticals and functional foods: CRC 902 press. 903 Wu, X.-M., Branford-White, C. J., Yu, D.-G., Chatterton, N. P., & Zhu, L.-M. (2011). Preparation of core-shell 904 PAN nanofibers encapsulated α-tocopherol acetate and ascorbic acid 2-phosphate for 905 photoprotection. Colloids and Surfaces B: Biointerfaces, 82, 247-252. 906 Xie, Z., Wang, F., Liu, H., Guo, S., Zhu, A., & Niu, H. (2010). Gelatin-walled microencapsulated diet for larval 907 shrimp (Penaeus japonicus Bate) manufactured using the fluidized bed coating process. 908 Aquaculture research, 42, 65-73. 909 Yaktine, A., & Pray, L. (2009). Nanotechnology in Food Products:: Workshop Summary: National Academies 910 Press. 911 Yang, Y., Decker, E. A., Xiao, H., & McClements, D. J. (2015). Enhancing vitamin E bioaccessibility: factors 912 impacting solubilization and hydrolysis of α-tocopherol acetate encapsulated in emulsion-based 913 delivery systems. Food & function, 6, 83-96. 914 Zempleni, J., Suttie, J. W., Gregory III, J. F., & Stover, P. J. (2013). Handbook of vitamins: CRC Press. 915 Zhou, W., Liu, W., Zou, L., Liu, W., Liu, C., Liang, R., & Chen, J. (2014). Storage stability and skin permeation 916 of vitamin C liposomes improved by pectin coating. Colloids and Surfaces B: Biointerfaces, 117, 330-917 337. 918\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n26\nZweers, M. L., Engbers, G. H., Grijpma, D. W., & Feijen, J. (2006). Release of anti-restenosis drugs from poly 919 (ethylene oxide)-poly (DL-lactic-co-glycolic acid) nanoparticles. Journal of Controlled Release, 114, 920 317-324. 921\n922\n923\nACCEPTED MANUSCRIPT\nACCEPTED MANUSCRIPT\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n3\nNano-liposome Chitosan nanoparticles\nVitamin C Improving the vitamin hydrophobicity and stability in\nthe delivery system\nLiu and Park (2009)\nNano emulsification Lecithin Thiamine dilauryl sulfate\n(TDS), a vitamin B derivative\nInhibiting spore germination of Fusarium oxysporum f. sp.\nRaphani using TDS in nanocapsuls\nCho et al., (2013)\nNano emulsification W1/O/W2 double emulsions with 4\ndifferent lipid sources\nVitamin B2 Using this process as functional healthier-fat food ingredients Bou et al., (2014)\nACCEPTED MANUSCRIPT\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n5\n(WPI) nanoparticles\nD3 (2013)\nNano emulsification Canola oil and Span80® Vitamin E acetate\nDeveloping a practical HPLC method to estimate vitamin E\nMorais et al., (2014)\nNano emulsification Medium chain triglyceride oil (MCT)\nVitamin E Studying the influence of cosolvents on formation and\nstability of vitamin E\nSaberi et al., (2013)\nNano emulsification Carrier oil (MCT, corn oil, fish oil, mineral oil or\norange oil)\nVitamin D3 Emulsifying and stabilizing capacities of natural surfactants\nOzturk et al., (2014)\nM AN\nUS\nCR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n1\nFig. 1. Microcapsule forms applied in vitamin encapsulation.\nM AN\nUS CR\nIP T\nAC\nCE\nPT ED\nACCEPTED MANUSCRIPT\n2\nFig. 2. Types of nanostructured delivery systems applied in vitamin encapsulation.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n3\nFigure 3. Prevalent approaches used to determine in vitro vitamin release profile\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n4\nFigure 4. Remarking the safety evaluation for vitamin Nanocarriers. GIT, gastrointestinal\ntract; ADME, adsorption, distribution, metabolism and excretion\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT Research Highlights\n• Importance of vitamin nanoencapsulation is compared to microencapsulation. • Microencapsulation techniques applied in vitamins are discussed. • Nanoencapsulation methods and nanocarriers applied in vitamins are reviewed. • Factors influencing the release rate of vitamins are highlighted. • Safety and risk evaluation issues are analyzed."
    } ],
    "references" : [ {
      "title" : "Stability of vitamin D 3 encapsulated",
      "author" : [ "A. Abbasi", "Z. Emam-Djomeh", "M.A.E. Mousavi", "D. Davoodi" ],
      "venue" : null,
      "citeRegEx" : "Abbasi et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Abbasi et al\\.",
      "year" : 2014
    }, {
      "title" : "Regulatory aspects of nanotechnology in the agri/feed/food",
      "author" : [ "H. J", "A. Mech", "L.Q. Pesudo" ],
      "venue" : null,
      "citeRegEx" : "J. et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "J. et al\\.",
      "year" : 2015
    }, {
      "title" : "Optimization of Folic Acid",
      "author" : [ "E. Assadpour", "Y. Maghsoudlou", "Jafari", "S.-M", "M. Ghorbani", "M. Aalami" ],
      "venue" : null,
      "citeRegEx" : "Assadpour et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Assadpour et al\\.",
      "year" : 2016
    }, {
      "title" : "Alginate/chitosan nanoparticles",
      "author" : [ "M.A. Azevedo", "A.I. Bourbon", "A.A. Vicente", "M.A. Cerqueira" ],
      "venue" : null,
      "citeRegEx" : "Azevedo et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Azevedo et al\\.",
      "year" : 2014
    }, {
      "title" : "PLGA nanoparticles in drug delivery: the state of the art",
      "author" : [ "I. Bala", "S. Hariharan", "M.R. Kumar" ],
      "venue" : null,
      "citeRegEx" : "Bala et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Bala et al\\.",
      "year" : 2004
    }, {
      "title" : "Vitamin delivery: Carriers based on",
      "author" : [ "S. Bochicchio", "A.A. Barba", "G. Grassi", "G. Lamberti" ],
      "venue" : null,
      "citeRegEx" : "Bochicchio et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Bochicchio et al\\.",
      "year" : 2016
    }, {
      "title" : "Physicochemical properties and riboflavin",
      "author" : [ "R. Bou", "S. Cofrades", "F. Jiménez-Colmenero" ],
      "venue" : null,
      "citeRegEx" : "Bou et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Bou et al\\.",
      "year" : 2014
    }, {
      "title" : "Powder composed of particles consisting of an oleophilic substance",
      "author" : [ "S. 693 Boyle", "Chang", "K.-T" ],
      "venue" : null,
      "citeRegEx" : "Boyle et al\\.,? \\Q1999\\E",
      "shortCiteRegEx" : "Boyle et al\\.",
      "year" : 1999
    }, {
      "title" : "The development of regulations for food nanotechnology",
      "author" : [ "699 Chau", "C.-F", "Wu", "S.-H", "Yen", "G.-C" ],
      "venue" : null,
      "citeRegEx" : "Chau et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Chau et al\\.",
      "year" : 2007
    }, {
      "title" : "Effect of nanoencapsulated vitamin",
      "author" : [ "J.S. Cho", "Y.C. Seo", "T.B. Yim", "H.Y. Lee" ],
      "venue" : null,
      "citeRegEx" : "Cho et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Cho et al\\.",
      "year" : 2013
    }, {
      "title" : "Inner core segment design for drug delivery control",
      "author" : [ "J.E. Chung", "M. Yokoyama", "T. Okano" ],
      "venue" : null,
      "citeRegEx" : "Chung et al\\.,? \\Q2000\\E",
      "shortCiteRegEx" : "Chung et al\\.",
      "year" : 2000
    }, {
      "title" : "Fabrication of solid lipid",
      "author" : [ "T.A. Comunian", "A. Abbaspourrad", "C.S. Favaro-Trindade", "D.A. Weitz" ],
      "venue" : null,
      "citeRegEx" : "Comunian et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Comunian et al\\.",
      "year" : 2014
    }, {
      "title" : "Transport and release in nano-carriers for food applications",
      "author" : [ "N. Dan" ],
      "venue" : "Journal of Food Engineering,",
      "citeRegEx" : "Dan,? \\Q2016\\E",
      "shortCiteRegEx" : "Dan",
      "year" : 2016
    }, {
      "title" : "Beta-casein assemblies for enrichment",
      "author" : [ "D. Danino", "Y.D. Livney", "O. Ramon", "I. Portnoy", "U. Cogan" ],
      "venue" : null,
      "citeRegEx" : "Danino et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Danino et al\\.",
      "year" : 2014
    }, {
      "title" : "Fabrication of Food grade Vitamin",
      "author" : [ "N. Dasgupta", "S. Ranjan", "S. Mundra", "C. Ramalingam", "A. Kumar" ],
      "venue" : null,
      "citeRegEx" : "Dasgupta et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Dasgupta et al\\.",
      "year" : 2016
    }, {
      "title" : "Potato protein based nanovehicles for health promoting hydrophobic",
      "author" : [ "S. David", "Y.D. Livney" ],
      "venue" : null,
      "citeRegEx" : "David and Livney,? \\Q2016\\E",
      "shortCiteRegEx" : "David and Livney",
      "year" : 2016
    }, {
      "title" : "Thermal and antimicrobial",
      "author" : [ "D. Dehnad", "H. Mirzaei", "Z. Emam-Djomeh", "Jafari", "S.-M", "S. Dadashi" ],
      "venue" : null,
      "citeRegEx" : "Dehnad et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Dehnad et al\\.",
      "year" : 2014
    }, {
      "title" : "Encapsulation of vitamin C in tripolyphosphate cross-linked chitosan",
      "author" : [ "K. 723 Desai", "H. Park" ],
      "venue" : null,
      "citeRegEx" : "Desai and Park,? \\Q2005\\E",
      "shortCiteRegEx" : "Desai and Park",
      "year" : 2005
    }, {
      "title" : "INFLUENCE of MALTODEXTRIN SYSTEMS ATAN EQUIVALENT",
      "author" : [ "S. Desobry", "F. Netto", "T. Labuza" ],
      "venue" : null,
      "citeRegEx" : "Desobry et al\\.,? \\Q1999\\E",
      "shortCiteRegEx" : "Desobry et al\\.",
      "year" : 1999
    }, {
      "title" : "Development of nanotechnologies",
      "author" : [ "A.P. Dowling" ],
      "venue" : "Materials Today,",
      "citeRegEx" : "Dowling,? \\Q2004\\E",
      "shortCiteRegEx" : "Dowling",
      "year" : 2004
    }, {
      "title" : "α-Tocopherol encapsulation and in vitro",
      "author" : [ "C. Duclairoir", "A. Orecchioni", "P. Depraetere", "E. Nakache" ],
      "venue" : null,
      "citeRegEx" : "Duclairoir et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Duclairoir et al\\.",
      "year" : 2002
    }, {
      "title" : "Nano-encapsulation of saffron extract",
      "author" : [ "A.F. 733 Esfanjani", "S.M. Jafari", "E. Assadpoor", "A. Mohammadi" ],
      "venue" : null,
      "citeRegEx" : "Esfanjani et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Esfanjani et al\\.",
      "year" : 2015
    }, {
      "title" : "Encapsulation in the food",
      "author" : [ "S.K.F. Gibbs", "Inteaz Alli", "Catherine N. Mulligan", "Bernard" ],
      "venue" : null,
      "citeRegEx" : "Gibbs et al\\.,? \\Q1999\\E",
      "shortCiteRegEx" : "Gibbs et al\\.",
      "year" : 1999
    }, {
      "title" : "Phosphatidylcholine, an edible carrier",
      "author" : [ "S.J. 738 Fathima", "I. Fathima", "V. Abhishek", "F. Khanum" ],
      "venue" : null,
      "citeRegEx" : "Fathima et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Fathima et al\\.",
      "year" : 2016
    }, {
      "title" : "Draft guidance for industry: Assessing the effects of significant manufacturingprocess",
      "author" : [ "FDA U" ],
      "venue" : null,
      "citeRegEx" : "U.,? \\Q2011\\E",
      "shortCiteRegEx" : "U.",
      "year" : 2011
    }, {
      "title" : "Physicochemical parameters associated",
      "author" : [ "S. Galindo-Rodriguez", "E. Allemann", "H. Fessi", "E. Doelker" ],
      "venue" : null,
      "citeRegEx" : "Galindo.Rodriguez et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Galindo.Rodriguez et al\\.",
      "year" : 2004
    }, {
      "title" : "New trends in encapsulation of liposoluble vitamins",
      "author" : [ "M. Gonnet", "L. Lethuaut", "F. Boury" ],
      "venue" : null,
      "citeRegEx" : "Gonnet et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Gonnet et al\\.",
      "year" : 2010
    }, {
      "title" : "Methods for the nanoencapsulation",
      "author" : [ "M. García-Suárez", "P. Gatón", "C. González-Ferrero" ],
      "venue" : null,
      "citeRegEx" : "J. et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "J. et al\\.",
      "year" : 2013
    }, {
      "title" : "Encapsulation of vitamin E: Effect",
      "author" : [ "J. 759 Hategekimana", "K.G. Masamba", "J. Ma", "F. Zhong" ],
      "venue" : null,
      "citeRegEx" : "Hategekimana et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Hategekimana et al\\.",
      "year" : 2015
    }, {
      "title" : "Vitamin C: the Real Story: The Remarkable and Controversial Healing Factor: Easyread",
      "author" : [ "S. Hickey" ],
      "venue" : null,
      "citeRegEx" : "Hickey,? \\Q2009\\E",
      "shortCiteRegEx" : "Hickey",
      "year" : 2009
    }, {
      "title" : "Encapsulation of nanoparticles of d-limonene by spray drying",
      "author" : [ "S.M. Jafari", "Y. He", "B. Bhandari" ],
      "venue" : null,
      "citeRegEx" : "Jafari et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Jafari et al\\.",
      "year" : 2007
    }, {
      "title" : "Optimization of nano-emulsions production",
      "author" : [ "S.M. Jafari", "Y. He", "B. Bhandari" ],
      "venue" : null,
      "citeRegEx" : "Jafari et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Jafari et al\\.",
      "year" : 2007
    }, {
      "title" : "Vitamin A loaded solid lipid nanoparticles",
      "author" : [ "V. 768 Jenning", "A. Gysler", "M. Schäfer-Korting", "S.H. Gohla" ],
      "venue" : null,
      "citeRegEx" : "Jenning et al\\.,? \\Q2000\\E",
      "shortCiteRegEx" : "Jenning et al\\.",
      "year" : 2000
    }, {
      "title" : "Effect of process",
      "author" : [ "V.B. Junyaprasert", "A. Mitrevej", "N. Sinchaipanid", "P. Boonme", "D.E. Wurster" ],
      "venue" : null,
      "citeRegEx" : "Junyaprasert et al\\.,? \\Q2001\\E",
      "shortCiteRegEx" : "Junyaprasert et al\\.",
      "year" : 2001
    }, {
      "title" : "The use of AC potentials in electrospraying and electrospinning",
      "author" : [ "R. Kessick", "J. Fenn", "G. Tepper" ],
      "venue" : null,
      "citeRegEx" : "Kessick et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Kessick et al\\.",
      "year" : 2004
    }, {
      "title" : "Preparation of vitamin E",
      "author" : [ "N. 779 Khayata", "W. Abdelwahed", "M. Chehna", "C. Charcosset", "H. Fessi" ],
      "venue" : null,
      "citeRegEx" : "Khayata et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Khayata et al\\.",
      "year" : 2012
    }, {
      "title" : "Stabilization of ascorbic acid",
      "author" : [ "C. 782 Kirby", "C. Whittle", "N. Rigby", "D. Coxon", "B. Law" ],
      "venue" : null,
      "citeRegEx" : "Kirby et al\\.,? \\Q1991\\E",
      "shortCiteRegEx" : "Kirby et al\\.",
      "year" : 1991
    }, {
      "title" : "Effects of particle size and surface modification on cellular uptake",
      "author" : [ "S.A. Kulkarni", "Feng", "S.-S" ],
      "venue" : null,
      "citeRegEx" : "Kulkarni et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Kulkarni et al\\.",
      "year" : 2013
    }, {
      "title" : "Size-dependent bioadhesion of micro-and nanoparticulate",
      "author" : [ "A. 787 Lamprecht", "U. Schäfer", "Lehr", "C.-M" ],
      "venue" : null,
      "citeRegEx" : "Lamprecht et al\\.,? \\Q2001\\E",
      "shortCiteRegEx" : "Lamprecht et al\\.",
      "year" : 2001
    }, {
      "title" : "Soy protein nano",
      "author" : [ "H. Lee", "G. Yildiz", "L. dos Santos", "S. Jiang", "J. Andrade", "N. Engeseth", "H. Feng" ],
      "venue" : null,
      "citeRegEx" : "Lee et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Lee et al\\.",
      "year" : 2016
    }, {
      "title" : "Study of emulsion stabilization",
      "author" : [ "C. Lemarchand", "P. Couvreur", "C. Vauthier", "D. Costantini", "R. Gref" ],
      "venue" : null,
      "citeRegEx" : "Lemarchand et al\\.,? \\Q2003\\E",
      "shortCiteRegEx" : "Lemarchand et al\\.",
      "year" : 2003
    }, {
      "title" : "Vitamin E bioavailability from fortified",
      "author" : [ "S.W. 795 Leonard", "C.K. Good", "E.T. Gugger", "M.G. Traber" ],
      "venue" : null,
      "citeRegEx" : "Leonard et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Leonard et al\\.",
      "year" : 2004
    }, {
      "title" : "Synergistic effects of whey protein",
      "author" : [ "B. Li", "Y. Jiang", "F. Liu", "Z. Chai", "Y. Li", "X. Leng" ],
      "venue" : null,
      "citeRegEx" : "Li et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2012
    }, {
      "title" : "2-hydroxypropyl-beta-cyclodextrin increases aqueous",
      "author" : [ "H. Lin", "C. Chean", "Y. Ng", "S. Chan", "P. Ho" ],
      "venue" : null,
      "citeRegEx" : "Lin et al\\.,? \\Q2000\\E",
      "shortCiteRegEx" : "Lin et al\\.",
      "year" : 2000
    }, {
      "title" : "Modeling aggregation and size distribution",
      "author" : [ "H.H. Liu", "S. Surawanvijit", "G. Orkoulas", "Y. Cohen" ],
      "venue" : null,
      "citeRegEx" : "Liu et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Liu et al\\.",
      "year" : 2016
    }, {
      "title" : "Chitosan-coated nanoliposome as vitamin E carrier",
      "author" : [ "N. Liu", "Park", "H.-J" ],
      "venue" : null,
      "citeRegEx" : "Liu et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Liu et al\\.",
      "year" : 2009
    }, {
      "title" : "Preparation and characterization of tea polyphenols and vitamin",
      "author" : [ "Q. Ma", "Y. Kuang", "X. Hao", "N. Gu" ],
      "venue" : null,
      "citeRegEx" : "Ma et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Ma et al\\.",
      "year" : 2009
    }, {
      "title" : "Vitamin B 12 loaded",
      "author" : [ "K. 814 Madhaiyan", "R. Sridhar", "S. Sundarrajan", "J.R. Venugopal", "S. Ramakrishna" ],
      "venue" : null,
      "citeRegEx" : "Madhaiyan et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Madhaiyan et al\\.",
      "year" : 2013
    }, {
      "title" : "Proteinlike copolymers as encapsulating agents for small-molecule",
      "author" : [ "R. 817 Malik", "J. Genzer", "C.K. Hall" ],
      "venue" : null,
      "citeRegEx" : "Malik et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Malik et al\\.",
      "year" : 2015
    }, {
      "title" : "Crocin loaded nano",
      "author" : [ "Mehrnia", "M.-A", "Jafari", "S.-M", "B.S. Makhmal-Zadeh", "Y. Maghsoudlou" ],
      "venue" : null,
      "citeRegEx" : "Mehrnia et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Mehrnia et al\\.",
      "year" : 2016
    }, {
      "title" : "Nano-encapsulation of olive leaf",
      "author" : [ "A. Mohammadi", "S.M. Jafari", "E. Assadpour", "A.F. Esfanjani" ],
      "venue" : null,
      "citeRegEx" : "Mohammadi et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Mohammadi et al\\.",
      "year" : 2015
    }, {
      "title" : "In vitro release testing methods for vitamin E nanoemulsions",
      "author" : [ "J.M. Morais", "D.J. Burgess" ],
      "venue" : null,
      "citeRegEx" : "Morais and Burgess,? \\Q2014\\E",
      "shortCiteRegEx" : "Morais and Burgess",
      "year" : 2014
    }, {
      "title" : "Nanotechnology for the food and bioprocessing industries",
      "author" : [ "S. Neethirajan", "D.S. Jayas" ],
      "venue" : null,
      "citeRegEx" : "Neethirajan and Jayas,? \\Q2011\\E",
      "shortCiteRegEx" : "Neethirajan and Jayas",
      "year" : 2011
    }, {
      "title" : "Formation and stabilization of nanoemulsion",
      "author" : [ "B. 835 Ozturk", "S. Argin", "M. Ozilgen", "D.J. McClements" ],
      "venue" : null,
      "citeRegEx" : "Ozturk et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Ozturk et al\\.",
      "year" : 2014
    }, {
      "title" : "Biodegradable nanoparticles for drug and gene delivery to cells",
      "author" : [ "J. 838 Panyam", "V. Labhasetwar" ],
      "venue" : null,
      "citeRegEx" : "Panyam and Labhasetwar,? \\Q2003\\E",
      "shortCiteRegEx" : "Panyam and Labhasetwar",
      "year" : 2003
    }, {
      "title" : "Characterization of ergocalciferol loaded solid lipid",
      "author" : [ "M.R. Patel", "S. Martin-Gonzalez", "M. Fernanda" ],
      "venue" : null,
      "citeRegEx" : "Patel et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Patel et al\\.",
      "year" : 2012
    }, {
      "title" : "Size-dependency of nanoparticle-mediated",
      "author" : [ "S. 850 Prabha", "Zhou", "W.-Z", "J. Panyam", "V. Labhasetwar" ],
      "venue" : null,
      "citeRegEx" : "Prabha et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Prabha et al\\.",
      "year" : 2002
    }, {
      "title" : "Nanoencapsulation I. Methods for preparation",
      "author" : [ "C.P. Reis", "R.J. Neufeld", "A.J. Ribeiro", "F. Veiga" ],
      "venue" : null,
      "citeRegEx" : "Reis et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Reis et al\\.",
      "year" : 2006
    }, {
      "title" : "Biopolymeric colloidal carriers for encapsulation or controlled",
      "author" : [ "C. Sanchez", "C. Schmitt" ],
      "venue" : null,
      "citeRegEx" : "Sanchez and Schmitt,? \\Q2002\\E",
      "shortCiteRegEx" : "Sanchez and Schmitt",
      "year" : 2002
    }, {
      "title" : "Encapsulation and controlled release of food ingredients",
      "author" : [ "S.J. Risch", "G. Reineccius" ],
      "venue" : null,
      "citeRegEx" : "Risch and Reineccius,? \\Q1995\\E",
      "shortCiteRegEx" : "Risch and Reineccius",
      "year" : 1995
    }, {
      "title" : "Fabrication of vitamin E-enriched nanoemulsions",
      "author" : [ "A.H. Saberi", "Y. Fang", "D.J. McClements" ],
      "venue" : null,
      "citeRegEx" : "Saberi et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Saberi et al\\.",
      "year" : 2013
    }, {
      "title" : "Nanotechnology and functional foods: Effective delivery",
      "author" : [ "M.C. Sabliov", "H. Chen", "R.Y. Yada" ],
      "venue" : null,
      "citeRegEx" : "Sabliov et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Sabliov et al\\.",
      "year" : 2015
    }, {
      "title" : "Nanoscale materials development–a food industry perspective",
      "author" : [ "P. Sanguansri", "M.A. Augustin" ],
      "venue" : null,
      "citeRegEx" : "Sanguansri and Augustin,? \\Q2006\\E",
      "shortCiteRegEx" : "Sanguansri and Augustin",
      "year" : 2006
    }, {
      "title" : "Novel technologies for the encapsulation of bioactive food",
      "author" : [ "L.G. Santiago", "G.R. Castro" ],
      "venue" : null,
      "citeRegEx" : "Santiago and Castro,? \\Q2016\\E",
      "shortCiteRegEx" : "Santiago and Castro",
      "year" : 2016
    }, {
      "title" : "Simultaneous controlled vitamin",
      "author" : [ "T. Seidenberger", "J. Siepmann", "H. Bley", "K. Maeder", "F. Siepmann" ],
      "venue" : null,
      "citeRegEx" : "Seidenberger et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Seidenberger et al\\.",
      "year" : 2011
    }, {
      "title" : "Casein micelle as a natural nano-capsular vehicle",
      "author" : [ "E. Semo", "E. Kesselman", "D. Danino", "Y.D. Livney" ],
      "venue" : null,
      "citeRegEx" : "Semo et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Semo et al\\.",
      "year" : 2007
    }, {
      "title" : "Vitamin E-loaded silk fibroin nanofibrous",
      "author" : [ "X. 875 Sheng", "L. Fan", "C. He", "K. Zhang", "X. Mo", "H. Wang" ],
      "venue" : null,
      "citeRegEx" : "Sheng et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Sheng et al\\.",
      "year" : 2013
    }, {
      "title" : "Preparation of chitosan/ethylcellulose complex microcapsule and its",
      "author" : [ "878 Shi", "X.-Y", "Tan", "T.-W" ],
      "venue" : null,
      "citeRegEx" : "Shi et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Shi et al\\.",
      "year" : 2002
    }, {
      "title" : "Mechanistic roles for",
      "author" : [ "M. Soares", "L. Murhadi", "A. Kurpad", "W. Chan She Ping-Delfos", "L. Piers" ],
      "venue" : null,
      "citeRegEx" : "Soares et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Soares et al\\.",
      "year" : 2012
    }, {
      "title" : "Vitamin-loaded electrospun cellulose acetate",
      "author" : [ "P. Taepaiboon", "U. Rungsardthong", "P. Supaphol" ],
      "venue" : null,
      "citeRegEx" : "Taepaiboon et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Taepaiboon et al\\.",
      "year" : 2007
    }, {
      "title" : "Biopolymer-coated liposomes by electrostatic",
      "author" : [ "C. Tan", "B. Feng", "X. Zhang", "W. Xia", "S. Xia" ],
      "venue" : null,
      "citeRegEx" : "Tan et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Tan et al\\.",
      "year" : 2016
    }, {
      "title" : "The influence of bile acids on the oral bioavailability of vitamin K",
      "author" : [ "C. Van Nostrum" ],
      "venue" : null,
      "citeRegEx" : "C. and Nostrum,? \\Q2009\\E",
      "shortCiteRegEx" : "C. and Nostrum",
      "year" : 2009
    }, {
      "title" : "Vitamin A Palmitate–β-cyclodextrin inclusion complexes: Characterization",
      "author" : [ "N. Vilanova", "C. Solans" ],
      "venue" : null,
      "citeRegEx" : "Vilanova and Solans,? \\Q2015\\E",
      "shortCiteRegEx" : "Vilanova and Solans",
      "year" : 2015
    }, {
      "title" : "Stabilization of the base-off forms of vitamin B12",
      "author" : [ "R. Wang", "B.C. MacGillivray", "D.H. Macartney" ],
      "venue" : null,
      "citeRegEx" : "Wang et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2009
    }, {
      "title" : "Functional materials in food nanotechnology",
      "author" : [ "J. Weiss", "P. Takhistov", "D.J. McClements" ],
      "venue" : null,
      "citeRegEx" : "Weiss et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Weiss et al\\.",
      "year" : 2006
    }, {
      "title" : "Handbook of nutraceuticals and functional foods: CRC",
      "author" : [ "R.E. Wildman", "R. Wildman", "T.C. Wallace" ],
      "venue" : null,
      "citeRegEx" : "Wildman et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Wildman et al\\.",
      "year" : 2006
    }, {
      "title" : "Preparation of core-shell",
      "author" : [ "Wu", "X.-M", "C.J. Branford-White", "Yu", "D.-G", "N.P. Chatterton", "Zhu", "L.-M" ],
      "venue" : null,
      "citeRegEx" : "Wu et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Wu et al\\.",
      "year" : 2011
    }, {
      "title" : "Gelatin-walled microencapsulated diet for larval",
      "author" : [ "Z. Xie", "F. Wang", "H. Liu", "S. Guo", "A. Zhu", "H. Niu" ],
      "venue" : null,
      "citeRegEx" : "Xie et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Xie et al\\.",
      "year" : 2010
    }, {
      "title" : "Nanotechnology in Food Products:: Workshop Summary: National Academies",
      "author" : [ "A. 909 Yaktine", "L. Pray" ],
      "venue" : null,
      "citeRegEx" : "Yaktine and Pray,? \\Q2009\\E",
      "shortCiteRegEx" : "Yaktine and Pray",
      "year" : 2009
    }, {
      "title" : "Enhancing vitamin E bioaccessibility: factors",
      "author" : [ "Y. Yang", "E.A. Decker", "H. Xiao", "D.J. McClements" ],
      "venue" : null,
      "citeRegEx" : "Yang et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Yang et al\\.",
      "year" : 2015
    }, {
      "title" : "Handbook of vitamins",
      "author" : [ "J. 914 Zempleni", "J.W. Suttie", "J.F. Gregory III", "P.J. Stover" ],
      "venue" : null,
      "citeRegEx" : "Zempleni et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Zempleni et al\\.",
      "year" : 2013
    }, {
      "title" : "Storage stability and skin permeation",
      "author" : [ "W. Zhou", "W. Liu", "L. Zou", "C. Liu", "R. Liang", "J. Chen" ],
      "venue" : null,
      "citeRegEx" : "Zhou et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Zhou et al\\.",
      "year" : 2014
    }, {
      "title" : "Release of anti-restenosis drugs",
      "author" : [ "M.L. Zweers", "G.H. Engbers", "D.W. Grijpma", "J. Feijen" ],
      "venue" : null,
      "citeRegEx" : "Zweers et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Zweers et al\\.",
      "year" : 2006
    }, {
      "title" : "Emulsion technique",
      "author" : [ "Shi", "Tan" ],
      "venue" : null,
      "citeRegEx" : "Shi and Tan,? \\Q2002\\E",
      "shortCiteRegEx" : "Shi and Tan",
      "year" : 2002
    }, {
      "title" : "Electrospraying and Nanospray drying",
      "author" : [ "Azevedo" ],
      "venue" : null,
      "citeRegEx" : "Azevedo,? \\Q2014\\E",
      "shortCiteRegEx" : "Azevedo",
      "year" : 2014
    }, {
      "title" : "Ionotropic gelation",
      "author" : [ "Fernández" ],
      "venue" : null,
      "citeRegEx" : "Fernández,? \\Q2014\\E",
      "shortCiteRegEx" : "Fernández",
      "year" : 2014
    }, {
      "title" : "2016) Nano-liposome coated by chitosan (chitosome",
      "author" : [ "Dasgupta" ],
      "venue" : null,
      "citeRegEx" : "Dasgupta,? \\Q2016\\E",
      "shortCiteRegEx" : "Dasgupta",
      "year" : 2016
    }, {
      "title" : "Solid lipid nanoparticles (SLNs",
      "author" : [ "Soares" ],
      "venue" : null,
      "citeRegEx" : "Soares,? \\Q2012\\E",
      "shortCiteRegEx" : "Soares",
      "year" : 2012
    }, {
      "title" : "Nano emulsification Medium chain triglyceride oil",
      "author" : [ "Morais" ],
      "venue" : null,
      "citeRegEx" : "Morais,? \\Q2014\\E",
      "shortCiteRegEx" : "Morais",
      "year" : 2014
    }, {
      "title" : "Nano emulsification Carrier oil (MCT, corn oil, fish oil, mineral oil or orange oil",
      "author" : [ "Saberi" ],
      "venue" : null,
      "citeRegEx" : "Saberi,? \\Q2013\\E",
      "shortCiteRegEx" : "Saberi",
      "year" : 2013
    } ],
    "referenceMentions" : [ {
      "referenceID" : 29,
      "context" : "skin, healing wounds, reducing cholesterol levels and regulating the blood sugar level, reducing neurological 46 disorders (vitamin C)(Hickey, 2009), preventing cancer and cardiovascular diseases as well as promoting 47 vigorous bones and teeth (vitamin D), restraining brain and nervous system diseases; such as, Alzheimer and 48 other dementias, boosting physical endurance and avoiding skin disorders (vitamin E), helping blood clot, 49 nerve signaling, improving bone health and regulating cellular functions (Zempleni, Suttie, Gregory III, & 50 Stover, 2013).",
      "startOffset" : 134,
      "endOffset" : 148
    }, {
      "referenceID" : 12,
      "context" : "Moreover, Danino, Livney, Ramon, Portnoy, 97 & Cogan, (2014) and Semo, Kesselman, Danino, & Livney, (2007) suggested that nanoencapsulation via ẞ98 cyclodextrins produced satisfactory sensory properties and created optically transparent solutions, however, 99 microemulsions tend to scatter light.",
      "startOffset" : 10,
      "endOffset" : 61
    }, {
      "referenceID" : 12,
      "context" : "Moreover, Danino, Livney, Ramon, Portnoy, 97 & Cogan, (2014) and Semo, Kesselman, Danino, & Livney, (2007) suggested that nanoencapsulation via ẞ98 cyclodextrins produced satisfactory sensory properties and created optically transparent solutions, however, 99 microemulsions tend to scatter light.",
      "startOffset" : 10,
      "endOffset" : 107
    }, {
      "referenceID" : 86,
      "context" : "274 Dasgupta, et al., (2016) formulated vitamin E acetate nanoemulsions (NE) by edible mustard oil and Tween 275 80 as surfactant.",
      "startOffset" : 4,
      "endOffset" : 29
    }, {
      "referenceID" : 85,
      "context" : "370 Jiménez-Fernández, et al., (2014) produced chitosan-based nanoparticles as a tool to deliver 371 vitamin C to marine organisms.",
      "startOffset" : 12,
      "endOffset" : 38
    }, {
      "referenceID" : 84,
      "context" : "446 Azevedo, Bourbon, Vicente, & Cerqueira, (2014) encapsulated vitamin B2 using alginate/chitosan 447 nanoparticles.",
      "startOffset" : 4,
      "endOffset" : 51
    }, {
      "referenceID" : 12,
      "context" : "In this period, the vitamins diffuse in 478 the hydrophilic environment (Dan, 2016).",
      "startOffset" : 72,
      "endOffset" : 83
    }, {
      "referenceID" : 10,
      "context" : "Poly butyl methacrylate and poly 558 N-isopropylacrylamide are some examples of temperature release components (Chung et al., 2000).",
      "startOffset" : 111,
      "endOffset" : 131
    }, {
      "referenceID" : 10,
      "context" : "Poly butyl methacrylate and poly 558 N-isopropylacrylamide are some examples of temperature release components (Chung et al., 2000). 559 Recently, Yang, Decker, Xiao, & McClements, (2015) exerted simulated small intestinal fluid (SSIF) 560 medium to examine the release rate and bioaccessibility of vitamin E trapped in O/W emulsions.",
      "startOffset" : 112,
      "endOffset" : 188
    } ],
    "year" : 2016,
    "abstractText" : null,
    "creator" : "Elsevier"
  }
}